Washington University in St. Louis

Washington University Open Scholarship
All Theses and Dissertations (ETDs)
Winter 1-1-2012

Multi-contrast Photoacoustic Microscopy
Junjie Yao
Washington University in St. Louis

Follow this and additional works at: https://openscholarship.wustl.edu/etd

Recommended Citation
Yao, Junjie, "Multi-contrast Photoacoustic Microscopy" (2012). All Theses and Dissertations (ETDs).
1025.
https://openscholarship.wustl.edu/etd/1025

This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has
been accepted for inclusion in All Theses and Dissertations (ETDs) by an authorized administrator of Washington
University Open Scholarship. For more information, please contact digital@wumail.wustl.edu.

WASHINGTON UNIVERSITY IN ST. LOUIS
School of Engineering & Applied Science
Department of Biomedical Engineering
Dissertation Examination Committee:
Lihong Wang, Chair
Mark Anastasio
Dennis Barbour
Joseph Culver
Jin-Moo Lee
Lan Yang

Multi-contrast Photoacoustic Microscopy
by
Junjie Yao

A dissertation presented to the
Graduate School of Arts and Sciences
of Washington University in
partial fulfillment of the
requirements for the degree
of Doctor of Philosophy
December 2012
St. Louis, Missouri

Contents
List of Figures ............................................................................................................................... vii
List of Tables .................................................................................................................................. x
Acknowledgements ........................................................................................................................ xi
Abstract ......................................................................................................................................... xii
1. Introduction ................................................................................................................................. 1
2. Optical-resolution photoacoustic microscopy............................................................................. 2
3. Multi-contrast photoacoustic microscopy ................................................................................... 6
3. 1. Photoacoustic microscopy of capillaries enhanced by Evans blue ..................................... 6
3.1.1. Methods......................................................................................................................... 7
Animal preparation ............................................................................................................. 7
Mode of injection of EB ..................................................................................................... 8
3.1.2. Results ........................................................................................................................... 8
Spatially continuous capillary imaging using EB as a contrast agent ................................ 8
Dynamics of EB diffusion out of the blood stream .......................................................... 10
Dynamics of the EBA clearance ....................................................................................... 12
3.1.3. Conclusions and discussion ........................................................................................ 14
3.2. Photoacoustic microscopy in transverse blood flow imaging............................................ 15
3.2.1. Methods....................................................................................................................... 16
3.2.2. Results ......................................................................................................................... 20

ii

Phantom study ................................................................................................................... 20
Animal study ..................................................................................................................... 23
3.2.3. Conclusions and discussion ........................................................................................ 27
3.3. Photoacoustic microscopy in total blood flow imaging ..................................................... 27
3.3.1. Methods....................................................................................................................... 28
3.3.2. Results ......................................................................................................................... 30
Phantom study ................................................................................................................... 30
Animal experiment............................................................................................................ 33
3.3.3. Conclusions and discussion ........................................................................................ 35
3.4. Photoacoustic microscopy in metabolic rate of oxygen measurement .............................. 36
3.4.1. Methods....................................................................................................................... 39
Hyperthermia experimental protocol ................................................................................ 40
Tumor cell culture ............................................................................................................. 40
Inoculation of tumor cells ................................................................................................. 41
Hemodynamics measured by mPAM ............................................................................... 41
Melanoma volume estimation using mPAM .................................................................... 43
Fitting for the profile of blood flow speed ........................................................................ 43
Statistical analysis ............................................................................................................. 44
3.4.2. Results ......................................................................................................................... 44
MRO2 quantification under normothermia ....................................................................... 44
iii

Change in MRO2 induced by systemic hyperthermia ....................................................... 45
Change in MRO2 induced by local cryotherapy ............................................................... 47
Early cancer detection by measuring tumor-induced change in MRO2 ............................ 49
3.4.3. Conclusions and discussion ........................................................................................ 55
4. Improvements in photoacoustic microscopy ............................................................................ 57
4.1. Double illumination photoacoustic microscopy ................................................................ 57
4.1.1. Methods....................................................................................................................... 58
4.1.2. Results ......................................................................................................................... 60
Phantom study ................................................................................................................... 60
Animal study ..................................................................................................................... 62
4.1.3. Conclusions and discussion ........................................................................................ 64
4.2. MEMS scanning mirror based fast scanning photoacoustic microscopy .......................... 65
4.2.1. Methods....................................................................................................................... 66
4.2.2. Results ......................................................................................................................... 69
Phantom study ................................................................................................................... 69
Animal study ..................................................................................................................... 71
4.2.3. Conclusions and discussion ........................................................................................ 74
5. Biomedical applications of multi-contrast photoacoustic microscopy (tomography) .............. 75
5.1. Immediate alterations in intestinal oxygen saturation and blood flow following massive
small bowel resection as measured by photoacoustic microscopy ........................................... 76
iv

5.1.1. Materials and methods ................................................................................................ 77
Experimental design.......................................................................................................... 77
Operative technique .......................................................................................................... 78
Intestinal sO2 and blood flow measured by photoacoustic microscopy ........................... 78
Statistical analysis ............................................................................................................. 79
5.1.2. Results ......................................................................................................................... 79
Arterial and venous oxygen saturation ............................................................................. 79
Tissue oxygen extraction .................................................................................................. 81
Arterial and venous blood flow......................................................................................... 82
5.1.3. Conclusions and discussion ........................................................................................ 83
5.2. Non-invasive photoacoustic tomography and microscopy of mouse brain metabolism in
vivo ............................................................................................................................................ 86
5.2.1. Materials and methods ................................................................................................ 88
2-NBDG ............................................................................................................................ 88
Noninvasive photoacoustic computed tomography (PACT) ............................................ 89
Optical-resolution photoacoustic microscopy (OR-PAM) ............................................... 89
Fluorescence imaging ....................................................................................................... 90
Animal preparation ........................................................................................................... 91
Forepaw stimulation.......................................................................................................... 92
Image co-registration ........................................................................................................ 93
v

Signal processing .............................................................................................................. 93
5.2.2 Results .......................................................................................................................... 96
PACT of 2-NBDG and blood phantom ............................................................................ 96
PACT of mouse brain ....................................................................................................... 97
PACT of cortical responses to forepaw stimulations........................................................ 98
Fluorescence imaging of cortical responses to forepaw stimulations ............................. 101
5.2.3. Conclusions and discussion ...................................................................................... 102
6. Future work ............................................................................................................................. 104
References ................................................................................................................................... 107

vi

List of Figures
Figure 1. Schematic of second-generation of optical-resolution photoacoustic microscopy ......... 3
Figure 2. EB enhanced photoacoustic imaging of mouse ear microvessels .................................. 9
Figure 3. Dynamics of EB diffusion out of the blood stream into surrounding tissue. ................ 11
Figure 4. Clearance dynamics of EBA.. ....................................................................................... 12
Figure 5. Quantitative analysis of EBA clearance. ....................................................................... 13
Figure 6. Probe-beam geometry for the transverse flow measurement. ....................................... 17
Figure 7. Sequential A-scans used to calculate the bandwidth broadening. ................................. 17
Figure 8. Bidirectional scanning to determine the flow direction. ............................................... 19
Figure 9. Photoacoustic flow measurement on microsphere phantom.. ....................................... 21
Figure 10. Photoacoustic flow imaging of microsphere phantom. ............................................... 22
Figure 11. PA imaging of sO2 and blood flow in a mouse ear. .................................................... 24
Figure 12. Quantitation of PA flow measurement in mouse ear................................................... 25
Figure 13. Blood flow measurement in a chicken embryo. .......................................................... 26
Figure 14. Total flow measurement on bovine blood. .................................................................. 31
Figure 15. Quantification of total flow measurement with fixed Doppler angle. ......................... 32
Figure 16. Doppler angle measurement on the bovine blood phantom. ....................................... 33
Figure 17. Three-dimensional PAM of a mouse ear. .................................................................... 34
Figure 18. Total flow measurement in mouse ear......................................................................... 35
Figure 19. mPAM measurements of sO2 and blood flow in the mouse ear. ................................. 39
Figure 20. Label-free quantification of metabolic rate of oxygen (MRO2) in vivo ..................... 45
Figure 21. mPAM measurement of hemodynamic responses to a hyperthermic challenge ......... 47
Figure 22. mPAM monitoring of hemodynamic responses after cryotherapy.............................. 48
vii

Figure 23. mPAM quantification of blood flow rate within 30 days after the treatment. ............ 49
Figure 24. mPAM detection of early-stage melanoma by measuring MRO2 .............................. 50
Figure 25. mPAM measurements in absolute units ..................................................................... 51
Figure 26. mPAM differentiation of blood vessels and melanoma. ............................................ 52
Figure 27. Histological validation of melanoma detection. .......................................................... 53
Figure 28. mPAM detection of early-stage glioblastoma by measuring MRO2. .......................... 54
Figure 29. Histological validation of glioblastoma detection. ..................................................... 55
Figure 30. Label-free mPAM of hypermetabolism and hyperoxia of early stage cancer ............ 56
Figure 31. . Schematic of DI-PAM. d1,2; Rayleigh range. .......................................................... 59
Figure 32. Lateral resolution under double illumination illumination.................................. 61
Figure 33. Penetration depth of double-illumination PAM. ......................................................... 61
Figure 34. DI-PAM of mouse ear in vivo. .................................................................................... 63
Figure 35. DI-PAM of the small intestine of a C57BL/6 mouse in vivo. ..................................... 64
Figure 36. Schematic of MEMS-OR-PAM. ................................................................................. 68
Figure 37. MEMS-scanning mirror............................................................................................... 69
Figure 38. Line spread function used to measure the lateral resolution of the system ................. 70
Figure 39. MEMS-OR-PAM imaging depth ................................................................................ 70
Figure 40. Scanning trace correction of MEMS-OR-PAM. ......................................................... 71
Figure 41. MEMS-OR-PAM of blood flow dynamics of the vasculature in a mouse ear. ........... 72
Figure 42. MEMS-OR-PAM of flow dynamics of carbon particles. ............................................ 74
Figure 43. Oxygen saturation (sO2) of the terminal mesenteric vessel .................................. 80
Figure 44. Photoacoustic microscopy images of intestinal microvascular structure .................... 81
Figure 45. Tissue oxygen utilization pre-operatively, post-sham, and post-SBR ........................ 82

viii

Figure 46. Blood flow of the terminal mesenteric vessel ............................................................. 83
Figure 47. 2-NBDG (C12H14N4O8). .......................................................................................... 88
Figure 48. Photoacoustic and fluorescence imaging systems. ...................................................... 91
Figure 49. Time course of forepaw stimulation. ........................................................................... 93
Figure 50. Multi-wavelength PACT in vitro and in vivo. ............................................................. 97
Figure 51. High-resolution OR-PAM imaging of the mouse brain after PACT imaging............. 98
Figure 52. PACT of the cortical responses to forepaw stimulations. ........................................... 99
Figure 53. Quantification of the cortical region covered by responding vessels. ....................... 100
Figure 54. Correlation of the hemodynamic response and glucose response. ............................ 101
Figure 55. Fluorescence imaging of mouse brain responses to forepaw stimulations................ 102

ix

List of Tables
Table 1. Comparison of fast scanning methods………………………………………………….66

x

Acknowledgements
I’d like to thank my advisor, Dr. Lihong Wang, whose mentoring and guidance is always the key
power that drives me through my PhD study. In addition to the academic supervising, Dr. Wang
also helps me to set up a high ethical standard which I will benefit from for my life. I’d also
appreciate useful discussions and help from all my lab members, especially Dr. Konstantin
Maslov, Dr. Lidai Wang, Chi Zhang, Dr. Dakang Yao, Dr. Song Hu, Dr. Amos Danielli, Arie
Krumholz and Dr. Amy Winkler. This work was sponsored by National Institutes of Health (NIH)
grants R01 EB000712, R01 EB008085, R01 CA134539, U54 CA136398, R01 CA157277, and
R01 CA159959.

xi

ABSTRACT OF THE DISSERTATION
Multi-contrast Photoacoustic Microscopy
by
Junjie Yao
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2012
Professor Lihong V. Wang, Chairperson
Photoacoustic microscopy is a hybrid imaging modality with high spatial resolution, moderate
imaging depth, excellent imaging contrast and functional imaging capability. Taking full
advantage of this powerful weapon, we have investigated different anatomical, functional, flow
dynamic and metabolic parameter measurements using photoacoustic microscopy. Specifically,
Evans-blue dye was used to enhance photoacoustic microscopy of capillaries; label-free
transverse and axial blood flow was measured based on bandwidth broadening and time shift of
the photoacoustic signals; metabolic rate of oxygen was quantified in vivo from all the five
parameters measured by photoacoustic microcopy; whole cross-sectional imaging of small
intestine was achieved on a double-illumination photoacoustic microscopy with extended depth
of focus and imaging depth; hemodynamic imaging was performed on a MEMS-mirror enhanced
photoacoustic microscopy with a cross-sectional imaging rate of 400 Hz. As a maturing imaging
technique, PAM is expected to find new applications in both fundamental life science and
clinical practice.
xii

1. Introduction
For centuries, the development of optical microscopes has revolutionized fundamental life
science and clinical practice [1]. By magnifying minuscule cellular and subcellular features,
optical microscopes provide a powerful tool for studying tissue components and their dynamic
interactions. Its excellent imaging contrast in soft tissue has made optical microscopy the most
widely used imaging modality in the biomedical community [1].
The visual power of optical microscopy relies on sharp optical focusing. Such power is rapidly
reduced as photons travel deeper into biological tissue, a highly scattering medium for
electromagnetic waves in the optical spectral range. When photons reach the optical diffusion
limit (~1 mm in tissue), they have typically undergone tens of scattering events, which
randomize the photon paths and thus prevent tight focusing [2]. Although modern optical
microscopic techniques have released biologists from the confines of ten-micrometer-thick ex
vivo tissue slices to a world of volumetric in vivo tissue, optical microscopy is still challenged to
image at depths beyond the optical diffusion limit while maintaining high resolution. For decades,
engineers have made scant progress by using pure optical approaches to fight scattering.
Fortunately, the emerging technique of photoacoustic tomography (PAT) has pointed out a new
direction, converting photon energy into ultrasound energy on the basis of the photoacoustic
effect [3-14].
In PAT, as photons travel in tissue, some of them are absorbed by biomolecules and their energy
is partially or completely converted into heat. The heat then induces an initial pressure rise,
which propagates in tissue as a wideband acoustic wave [15-17]. An ultrasonic transducer or
transducer array detects the acoustic wave to form an image, which maps the original optical
energy deposition in the tissue. Since ultrasonic scattering by tissue (~1.2 × 10-3 mm-1 in human
skin at 5 MHz) [18] is more than three orders of magnitude weaker than optical scattering (~10
mm-1 in human skin at 700 nm) [2], PAT can achieve fine acoustic resolution at depths beyond
the optical diffusion limit. In addition, since the photoacoustic signal amplitude is proportional to
the optical energy deposition, PAT is sensitive to the rich optical absorption contrast of tissue.
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Several previous Review articles have given comprehensive coverage of PAT, focusing on
instrumentation [4-6], contrast agents [8, 19], or biomedical applications [20-23]. The goal of
this paper is to review a major implementation of PAT, photoacoustic microscopy (PAM). PAM
has achieved spatial resolution ranging from sub-micrometer to sub-millimeter, at maximum
imaging depths ranging from a few hundred micrometers to a few millimeters [3, 6]. Distinct
from reconstruction-based PA computed tomography (PACT) [24-31], the other major
implementation of PAT, PAM employs raster-scanning of optical and acoustic foci and forms
images directly from acquired depth-resolved signals [3]. PAM maximizes its detection
sensitivity by confocally aligning its optical illumination and acoustic detection. While the axial
resolution of PAM is primarily determined by the imaging depth and the frequency response of
the ultrasonic transducer, its lateral resolution is determined by the combined point spread
function of the dual foci. PAM can be further classified into optical-resolution PAM (OR-PAM),
where the optical focusing is much tighter than acoustic focusing [32], and acoustic-resolution
PAM (AR-PAM), where the acoustic focusing is tighter [33, 34]. In addition, photoacoustic
endoscopy (PAE) is considered as a variant of PAM for internal organ imaging, which is
typically rotational scanning based. In PAM, while the depth-resolved acoustic waves render 1D
PA images (A-scan), two-dimensional raster scanning generates 3D PA images (C-scan).
In this dissertation, we will focus on the system construction and applications of OR-PAM. First,
we will introduce the system characteristics of OR-PAM, including the spatial resolution,
maximum imaging depth and imaging speed. Next, we will describe the different methods for
oxygen saturation, flow speed and metabolic rate of oxygen measurements in multi-contrast ORPAM. Then, we will highlight the improvements of OR-PAM in its imaging depth and imaging
speed. In the end, we envision future developments.

2. Optical‐resolution photoacoustic microscopy
The scalability of PAM originates from its optical and acoustic focusing [3]. Within the optical
diffusion limit, OR-PAM has a great advantage over AR-PAM in spatial resolution because the
optical beam can be easily focused to a much tighter spot than the acoustic detection, owing to
shorter optical wavelengths.
2

Figure 1. Schematic of second‐generation of optical‐resolution photoacoustic microscopy

Figure 1 shows a newly developed second-generation OR-PAM, which has shown a robust
capability to non-invasively image microvasculature using endogenous contrast with high spatial
resolution (lateral: ~5 µm; axial: ~15 µm) [32]. A tunable dye laser (CBR-D, Sirah) pumped by
a Nd:YLF laser (INNOSAB, Edgewave, 523 nm) serves as the light source. The laser pulse is
reshaped by a 25-µm–diameter pinhole and focused onto the surface of the mouse ear by a
microscope objective lens (Olympus 4×, NA=0.1) with a pulse energy of ~100 nJ. Ultrasonic
detection is achieved through a spherically focused ultrasonic transducer (V2012-BC,
Panametrics-NDT), which is placed confocally with the objective. The detected PA signal is then
amplified, digitized, and saved. A volumetric image is generated by recording the time-resolved
PA signal (A-line) at each horizontal location of the two-dimensional raster scan. The motion
controller provides the trigger signals for laser firing, data acquisition, and motor scanning.
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Since the acoustic focal diameter (~45 µm) is more than ten times as wide as the optical focal
spot, the detection sensitivity within the optical focus is approximately uniform. Therefore, the
lateral resolution of OR-PAM RL ,OR is given by the diffraction-limited spot size of the optical
focus [3, 35],

RL,OR  0.51

O
NAO

(1)

where O is the optical wavelength and NAO is the numerical aperture of the optical objective.
The constant 0.51 reflects the full width at half maximum (FWHM) of the optical focal spot in
light intensity. For a wavelength of 570 nm and an NAO of 0.13, the lateral resolution of G2-ORPAM was experimentally determined to be 2.56 µm, which agrees to Eq. (1) [36]. This
resolution is sufficient to resolve the cortical capillaries (diameter: 5-10 µm) of a nude mouse
with the scalp removed but skull intact. From Eq. (1), the lateral resolution of OR-PAM can be
scaled down by either increasing the objective NAO or using a shorter excitation wavelength,
with the maximum imaging depth scaled accordingly.
It should be pointed out that the lateral resolution of OR-PAM is the finest at the depth
corresponding to the focus of the optical objective for OR-PAM. At the two ends of the focal
zone, the lateral resolution degrades by

2 due to diffraction. The focal zone for OR-PAM can

be computed as ZOR  1.8O / NAO 2 . At the ends of twice the focal zone, the lateral resolution
degrades by a factor of 2.
The axial resolution of OR-PAM can be estimated by the formula, RA,OR / AR  0.88v A / f A , which
is based on the assumption that the PA response to a point target follows a Gaussian frequency
profile [3, 37]. f A is the PA signal bandwidth, which can be approximated as the detection
4

bandwidth of the ultrasonic transducer and is often proportional to its central frequency f A .
However, this is based on the assumption that the PA signal bandwidth is much wider than the
detection bandwidth. As mentioned above, high-frequency components of acoustic waves are
attenuated faster than low frequency ones, and thus, PA signal bandwidth decreases with
imaging depth, resulting in worse axial resolution at greater depths. Using ultrasonic transducers
with a central frequency of 50 MHz and a one-way -6 dB bandwidth of 100%, G2-OR-PAM in
Figure 1 has achieved the same axial resolution of 15 m.
The maximum imaging depth of OR-PAM is limited to ~1 mm in tissue due to optical scattering
[36]. The optical attenuation by tissue includes both absorption and scattering [2]. Compared
with absorption, scattering has a relatively weak dependence on wavelength. In general, an
excitation wavelength within the tissue optical window around 700 nm helps achieve a deeper
penetration because of the relatively low absorption of both hemoglobin and water, two major
absorbers in tissue [2, 38]. As a gold standard, OR-PAM can achieve a depth-to-resolution ratio
(DRR) of ~80. The DRR is defined as the ratio of the maximum imaging depth to the axial
resolution, representing the number of resolution pixels in the depth dimension.
As a high-resolution imaging modality, OR-PAM requires 2D raster scanning for 3D imaging.
Compared with confocal microscopy and two-photon microscopy, PAM does not need depth
scanning. Nonetheless, fast imaging speed is desirable to capture dynamics and eliminate motion
artifacts caused by breathing and heart beating. The traditional OR-PAM systems with ballscrew mechanical scanning have a typical cross-sectional (B-scan) scanning rate of 1 Hz [33-35].
This translates into an image acquisition time of 7 min for OR-PAM. Finer resolution PAM
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systems, such as SW-PAM, need more pixels per unit area, resulting in an even longer data
acquisition time [35].

3. Multi‐contrast photoacoustic microscopy
Originating from optical absorption, photoacoustic signals can be used to derive a number of
physical, chemical and functional parameters of the absorber and its microenvironment. Since a
single parameter may not be able to fully reflect the true physiological and pathological
conditions, multi-parameter PAM can provide a more comprehensive understanding, thus
benefiting the diagnosis, staging and treatment of diseases.

3. 1. Photoacoustic microscopy of capillaries enhanced by Evans blue
Total concentration of hemoglobin (CHb) is the most commonly used blood perfusion index. At
the isosbestic wavelengths of hemoglobin (e.g., 498 nm, 568 nm and 794 nm), the PA signal
amplitude reflects the CHb distribution in relative values, regardless of the oxygenation level of
hemoglobin [39].
However, RBC flow in capillaries is discontinuous and changes greatly over time [40-42].
Because RBCs are the only noticeable optical absorbers in capillaries, it is highly likely that no
absorber is present in a particular voxel during the laser pulse, which results in discontinuous
capillaries in a RBC-based PA image. In order to acquire a complete capillary image and gain
information about the capillary’s functional state[43], the use of an exogenic contrast agent is
compelling.
We use Evans Blue (EB) dye for this purpose. EB has strong absorption in visible and nearinfrared light, with a peak at 620 nm. EB is non-toxic and is used in measurement of blood
6

volume [44], lymph node location [45], microvascular permeability [46, 47], blood-retinal
barrier breakdown [48], capillary perfusion [42] and blood plasma flow [40] among other
applications. In the blood stream, EB mainly binds to serum albumin in a reversible manner, so it
is uniformly distributed in the plasma, maximizing the chance to get a complete capillary
network image. Under normal conditions, the EB-albumin (EBA) complex is confined to blood
vessels, while the free dye more readily diffuses out into extravascular tissue. The diffused dye is
bound to the surrounding tissue proteins, and finally cleared out by either metabolism or
excretion [49-52].
3.1.1. Methods
Animal preparation
The ears of adult, 6- to 8-week-old nude mice (Hsd: Athymic Nude-FoxlNU, Harlan Co.; body
weight: ~20 g) were used for all in vivo experiments here because their small thickness allowed
us to verify some of the PA results by using a standard bright field optical microscope. The nude
mouse ear model has a well-developed vasculature and has been widely used to study tumor
angiogenesis and other microvascular diseases [53]. Before data acquisition, the animal was
anaesthetized by an intraperitoneal injection of 85% ketamine and 15% xylazine (100 µl/g body
weight). During data acquisition, the animal was placed on a warming pan (37ºC), and its head
was held steady with a dental/hard palate fixture. The animal was kept still by using a breathing
anesthesia system (E-Z Anesthesia, Euthanex). After experiment, the animal recovered naturally
and was returned to its cage. All experimental animal procedures were carried out in conformity
with the laboratory animal protocol approved by the Animal Studies Committee of School of
Medicine at Washington University in St. Louis.
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Mode of injection of EB
A 6% or 3% EB w/v solution (Sigma, St. Louis, MO) was prepared by dilution of the dye in
phosphate-buffered saline (PBS, pH 7.5). Before injection, the solution was filtered through a 5µm filter. An intravenous injection of EB was made to either of the dorsal veins of the tail. The
injection lasted for about 10–20 seconds.
3.1.2. Results
Spatially continuous capillary imaging using EB as a contrast agent
Two irradiation wavelengths 570 nm and 610 nm were chosen for RBC imaging and EB imaging,
respectively. An area of 2 mm × 2 mm was chosen as the field of interest (FOI) near the margin
of the nude mouse ear, where the capillary density was higher. Before the dye injection, control
images were acquired with a scanning step size of 2.5 µm at 570 nm and 610 nm. The total
scanning time for a complete volumetric data set was ~30 min for each wavelength. In order to
get sufficient imaging contrast and sensitivity of the capillaries, a relatively high concentration of
EB in the blood plasma should be reached. Here 0.2 mL of 6% EB solution was injected in a
nude mouse (body weight: ~20 g). The total blood volume of the mouse was about 1.2 mL [54].
Thus the concentration of EB in the blood stream was ~1%, corresponding to an absorption
coefficient of ~1000 cm-1 at 610 nm [55], which is ~20 times higher than that of blood (~50 cm1

). Two PA images at 610 nm were acquired, one immediately after the dye injection and the

other 30 min later. Transmission optical microscopic images at 4× magnification were acquired
before and after injection.
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Figure 2. EB enhanced photoacoustic imaging of mouse ear microvessels. (a, b) PA microvascular image
before dye injection acquired at 570 nm (a) and at 610 nm (b). Arrows in (a) point to the fragmentary
capillaries. (c) PA image acquired at 610 nm right after EB (6%, 0.2 mL) injection via tail vein. Arrows in (c)
point to the continuous capillaries. (d) PA image acquired at 610 nm acquired 30 min after injection. (e, f)
Transmission microscopic images of the same area before (e) and after (f) injection. Arrows in (d), (e) and (f)
point to sebaceous glands. All the photoacoustic images were scaled to the same level of PA signal.

Before dye injection, a PA image was acquired at 570 nm. Hemoglobin has strong absorption at
this wavelength, which provided high imaging contrast and a high signal to noise ratio (>40 dB).
Veins and arteries larger than 10 µm in diameter contained a higher area density of RBCs and
appeared uniformly bright. However, smaller capillaries, containing a single of RBCs, looked
discontinuous and fragmentary. As a control, another image was acquired at 610 nm. The signal
was very weak due to the low hemoglobin absorption at 610 nm, which was only one-twentieth
of that at 570 nm. Right after the dye injection, the microvascular network appeared continuous
as shown in Fig. 2c. Dense capillaries could be observed, as indicated by arrows. All the
capillaries appear ‘broken’ in Fig. 2a became smooth and continuous. Moreover, the capillary
branching points that were invisible in Fig. 2a could be clearly distinguished. The blood vessels
9

in Fig. 2c appear somewhat thicker than those in Fig. 2a, which was possibly because the plasma
volume was larger than the RBC volume. The discernable blood vessel volume in the plasmabased image appeared to be more than 50% greater than that disclosed in the RBC-based image.
The image in Fig. 2d was acquired at 610 nm 30 min after dye injection. It shows that a
considerable amount of EB had diffused out of the blood vessels into the surrounding tissue but
did not diffuse into the sebaceous glands, which appear as brown patches in the transmission
microscopic images.
Dynamics of EB diffusion out of the blood stream
EB is removed from the vascular system principally by diffusing into extravascular tissue. At
high dye concentrations, in the first few hours, it is mainly the free EB rather than the EBalbumin complex that diffuses out. The fixation of the free EB molecules by tissue proteins
causes more dye to leave the blood to maintain chemical equilibrium, until the tissue proteins
become saturated [49-52, 56]. To better understand the diffusion dynamics, we monitored the
dye diffusion over time and quantified the diffused dye volume in the tissue. Here, a smaller area
of 1 mm × 1 mm was imaged near the margin of the nude mouse ear, so more data sets could be
acquired over time due to the shorter scanning time of ~10 min. Control images at 570 nm and
610 nm were acquired before dye injection. After 0.1 mL of 6% EB solution was injected, the
dye molar concentration in the plasma was ~0.52 mM, which was a high concentration compared
with the combination capability of albumin [52]. Right after injection, serial images at 610 nm
were acquired every 20 min until the dye diffusion was observed to have reached saturation.
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Figure 3. Dynamics of EB diffusion out of the blood stream into surrounding tissue. (a, b) PA images acquired
before EB injection at 570 nm (a) and at 610 nm (b). (c)‐(g) PA images acquired at 610 nm after EB (6%, 0.1
mL) injection at different times. (h) Partial volume of EB diffused into surrounding tissue. An exponential
recovery model was used to fit the experiment data. All the photoacoustic images were scaled to the same
level.

As before, control images at 570 nm and 610 nm were acquired before dye injection (Fig. 3a and
3b). The whole microvascular network within the field of view showed up with denser and more
continuous capillaries right after the 0.1 mL of 6% EB solution was injected (Fig. 3c). Sequential
images were acquired at different time points from 30 min to 120 min (Figs. 3d-g). The partial
volume of the free EB molecule diffused into extravascular tissue increased gradually and
reached a plateau after ~2 hours. If the dye left the blood vessels in a passive diffusion pattern,
the extravascular dye volume could be fitted by an exponential recovery model [57].

QT (t )  Qe [1  exp( kt )]

(2)

where QT (t ) , Qe are the dye volumes at time t and equilibrium, respectively, and k is the dye
diffusion rate. The fit result shows that EB indeed diffused in a passive pattern (Fig. 3h).
However, EB did not diffuse into the sebaceous glands, so more and more ‘dark cavities’ were
11

formed as the diffusion went on. Blood vessels were embedded in the diffused dye and
capillaries became nearly invisible.
Dynamics of the EBA clearance
At low dye concentrations, EB exists almost exclusively in the form of EBA [52]. EB permeates
wherever albumin is present. Therefore, the clearance dynamics of the EBA may be used to
estimate the albumin metabolic rate in tissue [52].

(a)

100 µm (b)

Before injection
(d)

Day 0
(e)

Day 1

Day 1/2
(f)

Day 3

Day 6

Day 4
(i)

(h)
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0
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Day 10

Normalized PA amplitude
1

Figure 4. Clearance dynamics of EBA. Before EB injection, (a) was acquired at 610 nm. On ½–10 days
following EB (3%, 0.05 mL) injection, images (b)‐(i) were acquired at 610 nm. All the photoacoustic images
were scaled to the same level.

To better understand the clearance dynamics, in our work the EBA volume in the tissue was
monitored by PA imaging. An imaging area of 1 mm × 1mm was chosen on the nude mouse ear,
and control images at 570 nm and 610 nm were acquired before dye injection. Then 0.05 mL of 3%
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EB solution was injected via the tail vein. Serial images were acquired at 610 nm every one or
two days, until EBA had nearly completely cleared out.
Before dye injection, Fig. 4a was acquired at 610 nm as a control image. Fig. 4b–i were acquired
on different days after dye injection. The EBA volume out of the blood vessels was calculated.
Quantified clearance was shown in Fig. 5. The EBA volume in the extravascular tissue reached
maximum on Day 3 and then decreased to the base line by Day 10.
A two-compartment model was used to fit the EBA volume in the extravascular tissue.

dQV
 k1QV
dt
dQT
 k1QV  k2QT
dt

(3)

where QV , QT are the EBA volumes in the blood stream and extravascular tissue, respectively.
k1 is the diffusion rate of EBA from the blood stream into the extravascular tissue, and k2 is the

clearance rate of EBA in the tissue. The results were consistent with the standard histological
studies of long term EBA decline [56, 58].
5
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Figure 5. Quantitative analysis of EBA clearance. After EB (3%, 0.05 mL) injection, the diffused EBA volume in
the surrounding tissue reached maximum on Day 3, and decayed to the baseline by Day 10. A two‐
compartment model was used to fit the experiment data.
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3.1.3. Conclusions and discussion
In this work, we demonstrate the feasibility of using Evans Blue dye as a contrast agent to
enhance in vivo photoacoustic microvascular imaging. Complete and continuous microvascular
networks especially capillaries were imaged with the contrast of EB. And as to our knowledge, it
is the first time that PA imaging has been used to study the dynamics of EB diffusion and EBA
clearance.
The photobleaching of EB may be crucial for quantitative study. In a previous study [55] for a
pulsed Nd:YAG laser (532 nm, 50 Hz, 14 ns pulse) and static 0.3% EB solution, photobleaching
started after 1 min irradiation with an energy deposition of 20 mJ/pulse cm2. In our study, the
energy pulse deposition was about 100 mJ/pulse cm2. However, the irradiation time was only 7
ns at each imaging position, which is much shorter than the reported photobleaching exposure
time. Therefore, the influence of photobleaching on the quantitative study can be ignored, and
the possibility that the apparent clearance of the dye was caused by photobleaching can be
excluded.
At high EB concentrations, it is mainly the free dye that passively diffuses out of the blood
vessels over tens of minutes. At low EB concentrations, as in most biological applications [40,
45, 47, 58, 59], it is mainly the EBA that diffuses out of the blood vessels, and thus it is usually
used as an indicator of the vessel leakage level. Our study was implemented under baseline
conditions, where the blood vessel was leakage-resistant for albumin, so relatively high EB
concentrations were used here to study the dynamics. However, a high contrast PA image does
not depend on whether free EB dye or EBA caused dye diffusion into extravascular tissue. The
key point here is that the potential application of PA imaging combined with EB for
physiological and pathological studies has been well demonstrated. Moreover, to test the imaging
14

sensitivity, a commonly used EB injection dose (30 mg/kg body weight) was used. The diffused
EBA can be clearly observed due to the high absorption contrast between the dye-protein
complex and background tissue hence the imaging sensitivity is sufficient for the biological
applications.
It is interesting that EB and EBA did not diffuse into the sebaceous glands, where ‘dark cavities’
were formed in the PA images, possibly caused by the denser structure or the biochemical
properties of the sebaceous glands. The physiological characteristics of sebaceous glands have
been thoroughly studied [60]. PA imaging facilitated by EB can provide three-dimensional
structural and functional information of sebaceous glands, which are very important growth
indexes during carcinoma development.

3.2. Photoacoustic microscopy in transverse blood flow imaging
Combining the spatial resolution of ultrasound imaging with the contrast of optical absorption in
deep biological tissues, photoacoustic imaging has been widely used in high-sensitivity structural
and functional imaging with micrometer-scale spatial resolution [26, 32, 33, 61]. It has also
shown the potential for measuring blood flow [62-64]. Previously, photoacoustic Doppler (PAD)
shift was observed from flowing particles illuminated by an intensity-modulated continuouswave (CW) laser beam [62, 63]. This physical phenomenon provides a basis for photoacoustic
Doppler flowmetry in optically scattering media [62]. However, the sensitivity of this method
depends mainly on the FFT time window, which limited the three-dimensional imaging speed
[65]. Furthermore, because a CW excitation source was used without frequency chirping, depth
could not be resolved. Like the other flowmetries based on the Doppler frequency shift, PAD
flowmetry was sensitive to the Doppler flow angle. In PA imaging of microvascular networks,
the transverse component of the flow is sometimes dominant.
15

When the Doppler angle

approaches 90º, the PAD frequency shift almost vanishes. Previous works in the fields of optical
coherence tomography and ultrasound imaging have demonstrated the feasibility of using the
bandwidth broadening to provide quantitative information on transverse flow [66-68]. However,
in those works the flow direction could not be determined due to the symmetry of the optical
objective or ultrasonic transducer. In the current work, we propose a method to measure both the
transverse flow speed based on bandwidth broadening and the flow direction based on
bidirectional scanning.
3.2.1. Methods
Sources of broadening include geometry, transit time, Brownian motion, velocity gradient and
turbulence [62, 66]. The contribution of Brownian motion to the overall broadening has been
shown to be small and consequently neglected [69]. The contributions of the velocity gradient
and turbulence can be minimized if the spatial resolution is high enough. The contributions of
transit time and geometry are equivalent within the focal region [70, 71]. and can be derived
either from diffraction theory or beam-to-flow ray theory, as shown in Fig. 6 [67].
The bandwidth, Bd , is given by
v
vW
sin 
Bd  2 f 0 sin  sin   f 0
c
c F
,

(4)

where v is the flow velocity; c is the speed of sound;  is the Doppler angle;  is the aperture
angle of the acoustic lens; and f0 , W , and F are the center frequency, the diameter, and the
focus length of the ultrasonic transducer, respectively. The bandwidth is proportional to the
transverse flow and is maximized when the Doppler angle is 90º.
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Figure 6. Probe‐beam geometry for the transverse flow measurement.
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Figure 7. Sequential A‐scans used to calculate the bandwidth broadening.

Because the resultant photoacoustic wave induced by pulse-laser excitation was wide-band, we
used the standard deviation of the sequential A-line scans to estimate the bandwidth broadening
(Fig. 7) [72, 73]. The digitized PA signal p (t ) was first passed through a digital bandpass filter
to increase the signal-to-noise ratio. The complex function p (t ) was determined by the Hilbert
transformation from p (t ) . The bandwidth broadening is given by
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where T is the time interval between sequential A-scans, n is the number of sequential scans
used to compute the standard deviation, and k is an experimentally determined constant factor
associated with the imaging system [72, 73]. The structural information was provided by the
envelope amplitude of each A-scan, and the flow information was provided by the bandwidth
broadening computed from sequential A-scans.
Here, it is necessary to point out that OR-PAM, where the RBC number within the tight optical
focus is limited, differs from the acoustic-resolution PAM (AR-PAM). In AR-PAM where the
acoustic focus provides the lateral resolution, the high RBC density may increase the difficulty to
detect the signal fluctuation caused by RBC flow. This can be potentially solved using low
concentration contrast agents, such as nanoparticles. The imaging depth then can be extended
into the diffuse regime. The proposed method should work in both cases, and the difference is
accounted for by k in Eq. (5).
In the current imaging system, the sample was translated by the scanning motor. Hence, the
bandwidth broadening was actually determined by the combination of the flow velocity and the
motor scanning velocity (Fig. 8). Therefore, a bidirectional scanning was used to determine the



flow direction. The motor first scanned with velocity vm  , and then switched to velocity vm  .



vm  has the same value as vm  but in the opposite direction. The measured flow speeds under the
two scanning directions are given by the combination speeds of the flow and the motor as
follows:
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v f _ m   (v f 2  vm 2  2v f vm cos  )1/2
v f _ m   (v f 2  vm 2  2v f vm cos  )1/2

(6)
,



where v f _ m  and v f _ m  are the measured speeds with motor-scanning velocities vm  and vm  ,

respectively; v m is the motor scanning speed;  is the angle between vm  and the flow velocity

v f , and cos  can be provided by structural PA imaging. Solving for the flow speed gives
 v 2f _ m  v 2f _ m

 4vm cos 
vf  
 2 2
1/2
v f _ m  v 2f _ m  2v 2 m 


 2

for   90
(7)

for   90

.

If v f _ m  v f _ m , we get   90 and vice versa. Therefore, the flow direction can be determined.
In case that v f _ m  v f _ m , which means that the flow is perpendicular to the motor-scanning
direction, the flow direction can be determined at other positions, because the flow path is
usually nonlinear.


vm 


v f _ m


vm 


v f _ m


vf

Figure 8. Bidirectional scanning to determine the flow direction.
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3.2.2. Results
Phantom study
A straight capillary tube (inner diameter: 260 µm) and a 0.1% solution of red-dyed particles
(diameter: 6 µm) were used to study the dependence of the bandwidth on the flow velocity. The
flow with speeds for 0 to 2.5 mm/s was controlled by a 1 mL syringe driven by a syringe pump
and illuminated at 570 nm. Although the scan angle can be generalized, in this instance, the


bidirectional scanning was along the tube (   0 ). The flow direction was the same as vm  .
In this experiment, we extracted the data from the center of the capillary (Fig. 9a,   90 ).
When the flow velocity was zero, the bandwidth broadening was caused only by the motor
scanning, no matter the scanning direction. When the scanning was in the same direction as the


flow ( vm  , square), the bandwidth increased as the flow speed increased. When the scanning was

opposite to the flow ( vm  , triangle), the bandwidth first decreased as the flow speed increased.
However, when the flow speed exceeded the scanning speed, the bandwidth began to increase.
The turning point indicated the motor-scanning speed v m . After subtraction of the contribution
of the motor scanning, the bandwidth profiles at the speeds of 2.3 mm/s (circle) and 1.6 mm/s
(square) are shown in Fig. 9b. A parabolic flow model was used to fit the experimental results
(solid curves). Data points on the bottom half of the capillary tube (the right side of the plot)
were fewer than on the upper half, because light penetration was limited.
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Figure 9. Photoacoustic flow measurement on microsphere phantom. (a) Bandwidth as a function of flow
velocity with a bidirectional motor scanning speed of 1.1 mm/s and Doppler angle of 90°. The motor



scanning direction was either the same as the flow direction ( vm  , square) or opposite to the flow direction



( vm  , triangle). Solid curves, theoretical predictions fitted with Eq. (2). Error bar, standard error. (b) Flow
profiles at flow velocities of 2.3 mm/s (circle) and 1.6 mm/s (square), after subtraction of the contribution of
the motor scanning. Solid curves, fitted parabolic flow profiles.

A tube laid in a zigzag pattern was used to get the structural and flow information simultaneously.
The flow speed was set to be 1.3 mm/s and the flow direction varied from segment to segment.
Three adjacent segments of the tube, denoted as S1 , S2 and S3 in Fig. 10a, were imaged. The
bidirectional scanning was along the longitudinal axis of these segments. The flow directions in



S1 and S3 were the same as vm  while the flow direction in S2 was the same as vm  .
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Figure 10. Photoacoustic flow imaging of microsphere phantom. (a) A transmission optical microscopy image
of three adjacent segments of a tube laid in a zigzag pattern. The flow directions in
as

S1 and S3 were the same



vm  , and the flow direction in S2 was the same as vm  . (b) A cross section of the structural image. The

approximate position of the cross section is indicated by the dashed line in (a). The scale bar for (b)‐(e) is
shown in (b). (c) The bandwidth image when the motor scanned in


vm  . (d) The bandwidth image when the


vm  . (e) The bandwidth image after subtraction of the contribution of the motor scanning.

The positive flow (with the same direction as vm  ) is shown in red and the negative flow (with the same

direction as vm  ) is shown in blue. (f) The speed profile indicated by the dashed line in (e).
motor scanned in

One cross section of the PA structural image is shown in Fig. 10b, and the approximate position
of the cross section is indicated by the dashed line in Fig. 10a. The measured bandwidths when



the motor scanned in vm  and vm  were quantified, as shown in Figs. 10c and 10d, respectively.

Because the flow directions in S1 and S3 were the same as vm  , and the flow direction in S2 was

opposite to vm  , the measured bandwidth in S1 and S3 was greater than that in S2 when the
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motor scanned in vm  (Fig. 10c). For the same reason, the measured bandwidth in S1 and S3 was

smaller than that in S2 when the motor scanned in vm  (Fig. 10d). After subtraction of the
contribution of the motor scanning, the bandwidth in all three segments became similar (Fig.
10e), which means that the flow speed within the tube was consistent. The positive flow (with



the same direction as vm  ) is shown in red and the negative flow (with the same direction as vm  )
is shown in blue. The negative bandwidth is only used to indicate the flow direction. The
calculated flow profile indicated by the dashed line in Fig. 10e is shown in Fig. 10f. At the
boundary of the tube, the particle density and the flow speed were relatively low, which resulted
in instability in the calculation. The signal from the tube wall also contributed to the calculation
error.
Animal study
In vivo experiment was performed on the ear of a 6-week-old mouse (Hsd:ND4, Swiss Webster;
Harlan, Indianapolis, IN). A volumetric dataset was acquired at 560 nm and 570 nm under
bidirectional scanning on a 2 mm × 1 mm area with a scanning speed of 0.75 mm/s and a step
size of 0.625 µm. The motor speed vibration (< 5% of the scanning speed) can be ignored in our
study. Before data acquisition, the animal was anaesthetized by an intraperitoneal injection with
a dose of 87 mg/kg ketamine and 13 mg/kg xylazine, and kept still by using a breathing
anesthesia system (E-Z Anesthesia, Euthanex). All experimental animal procedures were carried
out in conformity with the laboratory animal protocol approved by Washington University in St.
Louis. The PA signal acquired at 570 nm maps the total hemoglobin concentration, which
provides structural information of the vasculature (Fig. 11a). The dual-wavelength measurements
were used to calculate sO2 using a previously published method [74] (Fig. 11b). A trace of the
averaged sO2 values along the main vascular trunk is shown in Fig. 12a.
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Figure 11. PA imaging of sO2 and blood flow in a mouse ear. (a) MAP image of structure. Scale bar = 250 μm.
(b) MAP image of sO2 by measurements at 560 nm and 570 nm. (c) MAP image of blood flow speed with
magnitude only based on the Doppler broadening of bandwidth. (d) MAP image of blood flow velocity with
directions. The positive and negative flow directions are shown in pseudocolors.

Bidirectional scanning measurements at 570 nm were used to calculate the Doppler broadening
of bandwidth with eight sequential A-scans in one B-scan (Doppler angle: ~90 deg), which
provided the transverse blood flow images (Figs. 11c-d). Because the heart of a mouse beats at
up to ~8 Hz and the frame rate for B-scans was ~1 Hz, the bidirectional scans most likely caught
different phases of the systole and diastole. To mitigate the variation of the measured speed and
better determine the flow direction, we averaged over 3-by-3 pixels. The positive and negative
flows are shown in red and blue, respectively. A trace of the averaged speeds along the main
vascular trunk is shown in Fig. 12b. Velocity profile indicated by the dashed line in Fig. 11d is
shown in Fig. 12c. The flow speeds decrease from mother vessels to daughter vessels. The flow
directions can also help to distinguish arterioles from venules. The imaged vessels that flow
blood away from the heart are arterioles (marked in red in Fig. 11d), while the imaged vessels
that flow blood back to the heart are venules (marked in blue in Fig. 11d). This classification is
consistent with the categorization based on the sO2 measurement as shown in Fig. 11b.
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Saturation may exist here because the maximum measured speeds have reached the saturation
point observed in the phantom study.
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Figure 12. Quantitation of PA flow measurement in mouse ear. (a) Trace of SO2 values, averaged along the
main vascular trunk. (b) Trace of the blood flow speeds, averaged along the main vascular trunk. (c) Velocity
profile of the blood flow indicated by the dashed line in Figure 11(d).

Another experiment was performed on a stage-16 chicken embryo. The chicken embryo has been
widely used as a model to study the relationship between hemodynamics and circulatory diseases
[75]. For our study, since the chicken embryo has a relatively slow blood flow speed and heart
beating rate [75], the time course of the blood flow can be sufficiently sampled without speed
saturation. A chicken embryo was first removed from a fertile white leghorn chicken egg
(Sunrise Farms, Catskill, NY) after approximate 60 h of incubation and then cultured in
phosphate buffered saline (PH: ~7.0). Infrared light was applied to the embryo during the
experiment to maintain its activity (Temperature: ~30 ºC).
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Figure 13. Blood flow measurement in a chicken embryo. (a) Left: a transmission optical microscopy image of
a chicken embryo (stage 16). Scale bar = 2 mm. Right: a region of interest (~2 mm × 2 mm) imaged at a higher
magnification (×32). Scale bar = 500 µm. (b) A PA image of the same area. Scale bar = 500 µm. (d) Time
course of the blood flow speed at the position indicated by the cross in (b).

A transmission optical microscopy image of the entire embryo was acquired (Fig. 13a, left). An
area of ~2 mm × 2 mm around the right lateral vitelline vein was imaged at a higher
magnification (Fig. 13a, right), and a PA image of the same area was acquired at 570 nm (Fig.
13b). The time course of the flow speed at the center of a vessel, marked by a cross in Fig. 13b,
was measured using eight sequential A-scans without motor scanning. The Doppler angle was
~90 deg. The forward and backward flows are clearly observed (Fig. 13c). The measured flow
speeds are consistent with those observed previously in ovo [75]. The opposite flow directions
were confirmed using the optical microscopy. The spectral analysis of the time course indicates a
heart beating rate of ~0.5 Hz, which is consistent with the visual observation.
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3.2.3. Conclusions and discussion
In theory, the maximum measurable speed is ~7.4 mm/s, which is limited by the 2 kHz
maximum laser repetition rate and the light focus diameter in our system. It can be improved by
increasing the laser repetition rate or enlarging the light focal spot. Both the minimum
measurable speed and the speed sensitivity are around 0.1 mm/s, which are determined by the
signal-to-noise ratio (SNR), which can be improved by averaging multiple measurements. With
motor scanning, small vessels may not have sufficient SNR to keep the speed sensitivity. This
problem can be solved by increasing the A-scan repetition rate or switching to M-mode
measurement. The latter, however, will lose the flow direction information.
Bidirectional scanning can help to determine the flow direction along the scanning line. However,


if vf is perpendicular to the scanning line, which gives v f _ m  v f _ m , the direction cannot be
determined. One solution is to determine the flow direction at other positions of the same blood
vessel. Another solution is to use four-directional scanning, including back and forth scanning
along two orthogonal scanning lines. All the flow directions can be covered at the expense of
imaging time.

3.3. Photoacoustic microscopy in total blood flow imaging
So far, photoacoustic flow measurements have focused on either the axial [76-79] or transverse
[64, 80-83] component of the flow vector. However, to quantify the total flow vector, the
Doppler angle (angle of the flow direction relative to the axis of the received acoustic wave) is
needed. The Doppler angle can be estimated by tracing the vessel centerline either manually or
automatically in a volumetric image. In practice, however, volumetric information is not always
available, as in the case of M-mode imaging. In addition, despite the additional time required for
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volumetric imaging, accurate estimation of the Doppler angle is challenging if the system's axial
and lateral resolutions are too different. Here, using PAM, we propose a simple method for
measuring total flow and the Doppler angle by combining the axial and transverse flow
measurements. Briefly, the axial flow speed is estimated from the phase shift between
consecutive Hilbert transformed pairs of A-lines [65]. The sign of the phase shift provides the
axial flow direction. The transverse flow speed is quantified from the bandwidth broadening via
the Fourier transformation of sequential A-lines [81]. The transverse flow direction can be
measured by bi-directional scanning [81]. We first verified this method by flowing bovine blood
in a plastic tube (inner diameter: 200 µm) at different total speeds (0–7.5 mm/s) and Doppler
angles (30–330º). Then, in a mouse ear, we measured the total flow speed and Doppler angle in
vivo.
3.3.1. Methods
Inspired by previous work in ultrasound imaging [84] and optical coherence tomography [65],
we use the following formula to compute the axial component va pixelwise:

va 

1 c 
,
 
2 T f 0

(8)

where c is the speed of sound in water (1500 m/s), T is the time interval between the two
consecutive A-lines acquired in M-mode,  is the phase shift in each pixel between two
consecutive A-lines, and f0 is the central frequency of an ultrasonic transducer. The phase shift
 is quantified via the Hilbert transformation. The sign of  provides the axial flow direction,

where positive  means a flow towards the ultrasonic transducer and vice versa. The axial flow
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velocity va is related to the total flow velocity v through v  cos( ) , where  is the Doppler
angle (Fig. 6).
It has also been demonstrated above that the transverse flow component vt , which equals

v  sin( ) , can be estimated based on Eq. (4) [66, 67, 81] . For a PAM system with confocal
alignment but different optical and acoustic focal sizes, k in Eq. (4) mostly accounts for the
discrepancy in the two foci. In the case of the optical-resolution PAM (OR-PAM) used in this
study [32], shown in Fig. 1, where the optical focusing (~5 μm) is much tighter than the acoustic
focusing (~45 μm), Bd mainly comes from the PA amplitude fluctuation caused by particles
passing through the optical focal zone. Therefore, k is mostly determined by the beam geometry
of the optical focusing and equals 0.02 here. Several other minor factors, such as Brownian
motion, particle size and shape, and velocity distribution across the focal zone may contribute to

Bd . Since all these bandwidth broadening mechanisms have a linear dependence on the mean
transverse velocity [76], their contributions can also be incorporated into k . The transverse flow
direction can be measured by bi-directional scanning, as long as the transverse flow is not
perpendicular to the scanning line [81]. If the transverse flow has a positive projection along the
positive scanning direction, we define it as a positive flow, and vice versa.
From the axial and transverse flow components, the Doppler angle  can be derived as

  tan 1 (v t / v a ) , which ranges from 0° to 360°. Since the inverse tangent covers angles ranging
only from –90° to 90°,  needs to be adjusted according to the flow direction. In Matlab,
function tan2 can be used instead of tan to account directly for the flow direction. The total flow
speed

v is computed by v  v a2  v t2 .
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3.3.2. Results
Phantom study
Defibrinated oxygenated bovine blood (B-A8775, Materials Bio, hematocrit: 44%) was used for
the flow phantom. The blood flowed in a transparent plastic tube (508-001, Silastic, inner
diameter ~200 µm), driven by a syringe pump (BSP-99M, Braintree Scientific) with a 5 mL
syringe (Multifit; Becton, Dickinson & Co). Two experiments were performed using this
phantom. First, by changing the pumping speed, the mean flow speed was adjusted from 0 to 7.5
mm/s, with a step size of 0.25 mm/s, while the Doppler angle was fixed at 30º. Second, by
mounting the tube on a goniometer stage (GN05, Thorlabs), the Doppler angle was adjusted from
30º to 330º with a step size of 30º, while the mean total flow speed was fixed at 1.0 mm/s. If we
take the blood density as 1060 kg/m3 and the blood viscosity as 3×10-3 kg/(m·s) at room
temperature, the Reynolds number was estimated to be far less than 1. Therefore, the flow in the
tube was considered to be laminar [85]. It is worth mentioning that the 1/e penetration depth of
light at 590 nm in oxygenated blood is ~130 µm, which is greater than the radius of the plastic
tube.
In the phantom studies, 3200 consecutive A-lines were acquired at each position across the tube
(M-mode). For axial flow measurement, each A-line was passed through a digital band-pass filter
centered at 50 MHz, with a –6 dB bandwidth of 20%. A moving smoothing operation was then
performed over each eight sequential A-lines to increase SNR. Fig. 14a is a typical M-mode
image across the center of the tube, with a Doppler angle of 30° and mean total flow speed of
1.25 mm/s. Fig. 14b shows three representative A-lines with a time interval of 3.3 ms. The axial
flow speed profile was then calculated from the average phase shift between two consecutive Alines after each A-line was Hilbert transformed. For transverse flow measurement, the original
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data without filtering was used. The transverse flow was quantified along the lateral direction at
each depth, where the bandwidth was computed via the Fourier transformation [80, 81].

Figure 14. Total flow measurement on bovine blood. (a) An M‐mode image of the tube with a Doppler angle of
30° and mean total flow speed of 1.25 mm/s after passing through a digital filter. The dashed lines indicate
the top and bottom boundaries of the tube. (b) Three representative consecutive A‐lines with a time interval
of 3.3 ms, where t0 is indicated by the arrow in (a). The horizontal dashed lines indicate the top and bottom
boundaries of the tube. The oblique dashed line shows the phase shifts among these A‐lines.

A laminar flow model was used to fit the flow speed profiles along the axial and transverse
directions of the tube [86]:

v( x, z )  vmax (1 

( x  x0 ) 2  ( z  z0 ) 2
).
R2

(9)

Here, x and z are the transverse and axial coordinates, respective, ( x0 , z0 ) are the tube center
coordinates, R is the tube radius, and vmax is the flow speed at the tube center. While ( x0 , z0 )
and R can be measured directly from the cross-sectional image of the tube, vmax is the unknown
parameter to be fitted for.
For the first phantom study, representative axial and transverse flow profiles calculated from Fig.
14a are shown in Fig. 15a. The measured mean axial and transverse speeds were 1.10 ± 0.09
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mm/s and 0.65 ± 0.02 mm/s, respectively. The measured mean total flow speed is 1.28 ± 0.09
mm/s, and the measured Doppler angle is 30.6 ± 3.0º, which agrees with the preset value of 30º.
Fig. 15b shows the measured mean axial, transverse, and total flow speeds as well as the Doppler
angle as a function of the preset speeds. The Doppler angle was not calculated at zero flow speed.
From the results, the measured speeds agree well with the preset speeds, and the calculated
Doppler angles average 31.0 ± 2.7º. The speed measurement errors are less than 0.3 mm/s.
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Figure 15. Quantification of total flow measurement with fixed Doppler angle. (a) Transverse and axial speed
profiles from Figure 14(a). (b) Measured transverse, axial, total flow speeds as well as the Doppler angle
versus the preset total flow speed.

For the second phantom study, Fig. 16a shows representative axial and transverse flow profiles
with the same mean total flow speed of 1.0 mm/s but two different Doppler angles (60º and 70º).
The weighted mean axial and transverse speeds at 60º measure 0.45 ± 0.03 mm/s and 0.80 ± 0.03
mm/s, respectively, yielding a total flow speed of 0.92 ± 0.03 mm/s and a Doppler angle of 60.6
± 1.9º. The weighted mean axial and transverse speeds at 70º measure 0.33 ± 0.02 mm/s and 0.92
± 0.10 mm/s, respectively, yielding a total flow speed of 0.98 ± 0.09 mm/s and a Doppler angle
of 70.3 ± 2.3º. Furthermore, the measured Doppler angles as a function of preset angles are
shown in Fig. 16b, which shows good agreement, within 15º.
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Figure 16. Doppler angle measurement on the bovine blood phantom. (a) Measured speed profiles of the axial
and transverse flow along the depth direction, with the same total flow speed (mean: 1.0 mm/s) but different
Doppler angles (60° and 70°). T: transverse; A: axial. (b) Measured Doppler angles as the function of preset
values.

Animal experiment
The left ear of an adult, 8-week-old nude mouse (Hsd: Athymic Nude-FoxlNU, Harlan Co.; body
weight ~20 g) was imaged in vivo. During data acquisition, the animal was held steady with a
dental/hard palate fixture, and kept still by using a breathing anesthesia system (E-Z Anesthesia,
Euthanex). An area of 1.0×0.5 mm2 at the base of the ear was chosen for total flow measurement.
A bi-directional scan was performed over this area to measure the transverse flow direction.
Oxygen saturation was then imaged on the same area with 584 nm and 590 nm optical
wavelengths. After the experiment, the animal recovered naturally and was returned to its cage.
The flow processing for the in vivo experiment was the same as that for the phantom study,
except that a 1.0×0.5 mm2 area instead of only a cross-section was imaged. The absolute CHb and
sO2 were computed using the previously published acoustic spectral method [87] and multiwavelength method [88], respectively.
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A typical artery-vein pair at the base of a nude mouse ear was imaged (Fig. 17a). The
morphology indicates that the thicker vessel of the pair is the vein, which is confirmed by the sO2
measurement (Fig. 18a). The volumetric rendering (Fig. 17b) shows that the Doppler angles of
the artery and vein at the proximal ends were approximately 82.5º and 255.5º, respectively (Fig.
17c).

Figure 17. Three‐dimensional PAM of a mouse ear. (a) Maximum amplitude projection of the total
hemoglobin concentration image of an artery‐vein pair of the mouse ear. Scale bar: 100 μm. CHb: total
hemoglobin concentration. (b) Volumetric rending of the same area as (a). Scale bar: 100 μm. (c) Sagittal
cross‐section images of the artery (top) and vein (bottom), indicated by the dashed and solid arrows in (b),
respectively. The Doppler angles were estimated to be 82.5° and 78.5°, respectively. Scale bar: 100 μm.

The maximum projection of total flow speed is shown in Fig. 18b, where the artery has faster
flow than the vein. The transverse speeds at the centers of the artery and vein were 3.9 ± 0.25
mm/s and 1.1 ± 0.20 mm/s, respectively, as shown in Fig. 18c. The transverse flow directions
show that the blood in the artery indeed flowed from the proximal end to the distal end, and
flowed in the opposite direction in the vein. The axial speeds at the centers of the artery and vein
were 0.9 ± 0.25 mm/s and 0.4 ± 0.02 mm/s, respectively, as shown in Fig. 18d. The axial flow
directions show that the blood flowed towards the transducer in the artery, but away from the
transducer in the vein. Based on the above information, the total flow speeds at the centers of the
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artery and vein were 4.0 ± 0.25 mm/s and 1.2 ± 0.19 mm/s, respectively. The Doppler angles at
the centers of the artery and vein were 77.0 ± 3.6º and 250.0 ± 3.5º, respectively, which were
consistent with the measurements from the volumetric image.

Figure 18. Total flow measurement in mouse ear. (a) sO2 image of the same area as that in Fig. 17. (b) Total
flow speed image of the same area. (c) Transverse speed profiles along the dashed line in (b). Positive
transverse flow direction: from left to right. (d) Axial speed profiles along the depth direction at the centers of
the artery and vein, indicated by the arrows in (b). Positive axial flow direction: towards the ultrasonic
transducer.

3.3.3. Conclusions and discussion
We have demonstrated a method for measuring both total flow velocity and Doppler angle using
PAM. By Combining blood flow information with other anatomical and functional parameters
such as vessel cross-sections, CHb and sO2, we can quantify the metabolic rate of oxygen (MRO2)
for cancer hypermetabolism studies [89]. The advantage of this method is simplicity: No system
modification or additional data acquisition is required to use our existing PAM. Both the axial
and transverse flow components are measured in M-mode. Collating the A-lines side by side
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yields a 2D matrix. The axial direction of this matrix (column) is called the fast axis (depth),
whereas the lateral direction (row) is called the slow axis (time). The columns are Hilbert
transformed to compare the phases for the computation of the axial flow. The rows are Fourier
transformed to quantify the bandwidth for the computation of the transverse flow.
In general, both axial and transverse flow directions should be measured to determine the total
flow direction. Because blood can only flow along the blood vessels, only one of the two
directions is required to be measured as long as the blood vessel can be resolved precisely.
However, when there is no axial flow and the transverse flow direction is perpendicular to the bidirectional scanning, four-directional scanning is required.
In theory, the maximum measurable axial and transverse flow speeds are 60.0 mm/s and 21.2
mm/s, respectively, limited by the 3 kHz PRF [65, 78, 81]. The minimum measureable axial and
transverse speeds are ~0.1 mm/s, determined by the PRF and SNR [78, 81, 90]. In our studies,
since the PRF can be as slow as 1 Hz at the expense of imaging speed, it is the SNR that limits
the minimum measureable speeds.

3.4. Photoacoustic microscopy in metabolic rate of oxygen measurement
The energy demand of mammals is met primarily by aerobic metabolism, producing 88% of
ATP molecules [91]. Therefore, the metabolic rate of oxygen (MRO2) is an important indicator
of tissue viability and functionality. It is known that nearly all cancers after the early stage are
starved for oxygen (hypoxia) due to hypermetabolism and/or limited blood supply, regardless of
their cellar origins [92]. In the presence of low oxygen pressure, highly malignant cancer cells
survive and proliferate via glycolysis (anaerobic respiration, the Warburg effect). The presence
of a large number of hypoxic regions within a tumor usually correlates with a poor prognosis
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[91]. This metabolic phenotype has become the basis for tumor imaging by positron emission
tomography (PET) using radioactively labeled oxygen. Many other pathological and
physiological functions are also closely related to alterations of oxygen metabolism: examples
include Alzheimer's disease [93], diabetes [94], burns [95], obstructive pulmonary disease [96],
congestive heart failure [97], aging [98], sleeping [99], and physiologic challenges [100].
Therefore, an accurate measurement of MRO2 has the potential to provide a powerful tool for
diagnosis and therapy of cancer and other diseases as well as for metabolism-related
pathophysiological studies.
Compared with other oxygenation indexes of tissue, i.e., oxygen saturation of hemoglobin (sO2)
and partial oxygen pressure (pO2), MRO2 is superior because it directly reflects the rate of
oxygen consumption instead of the static oxygen concentration [101]. If the region of interest has
well-defined feeding and draining vessels, we have [5]

MRO2 =  CHb  sO2in  Ain  vin  sO2out  Aout  vout  / W.

(10)

Here, subscripts in and out denote feeding and draining vessels, respectively.  is the oxygen
binding capacity of hemoglobin and is usually taken as a constant (1.36 ml O2/gram hemoglobin)
[102]. CHb is the total hemoglobin concentration (in grams of hemoglobin/ml blood). sO2 is the
average oxygen saturation (in %). A is the cross-sectional area (in mm2). v is the average blood
flow speed (in mm/s). W is the weight of the region of interest (in grams). While CHb can be
estimated anywhere in the trunk vasculature, the other parameters must be measured locally.
Presently, three primary imaging modalities are used to quantify MRO2 [5]. Among them, PET is
most widely used in clinical practice. However, the need for injection or inhalation of
radioactively labeled exogenous tracers results in a complex procedure with exposure to ionizing
37

radiation, limiting its usage [103]. Functional magnetic resonance imaging (fMRI) has also been
intensively used for MRO2 study, especially in the brain. fMRI is limited to qualitative
evaluation of only temporal changes in MRO2 and has difficulty in measuring both CHb and sO2
[104]. It also must switch between different imaging protocols to measure sO2 and v [105, 106].
Moreover, both PET and fMRI are expensive. Diffuse optical tomography (DOT) is also capable
of measuring MRO2 and is relatively inexpensive, but it relies on an approximate theoretical
model or other techniques (e.g., Doppler ultrasound and laser Doppler) to provide blood flow
information [107, 108]. Recently, DOT has been combined with diffuse correlation spectroscopy
(DCS), which is capable of providing relative blood flow information [109]. Furthermore, due to
their relatively poor spatial resolutions, PET, fMRI and DOT usually measure MRO2 averaged
over a large volume [21].
Here, we overcome these limitations by using photoacoustic microscopy.We demonstrated that
all five anatomic, chemical and fluid-dynamic parameters for MRO2 quantification can be
obtained in absolute units by mPAM alone in vivo. Specifically, All the parameters for MRO2
quantification in Eq. (10) can be simultaneously obtained by mPAM. Specifically, anatomic
parameters W and A are quantified from the structural mPAM image [74]; functional
parameters CHb and sO2 are measured by laser excitation at two wavelengths [33, 74]; fluiddynamic parameter v is estimated on the basis of photoacoustic bandwidth broadening of the
PA signal induced by circulating red blood cells [80, 110]. The structural image acquisition time
is ~25 min for a 4 mm × 4 mm region (~1 Hz frame rate) using single wavelength; the
oxygenation image acquisition time is ~20 min for a 1 mm × 1 mm region using two
wavelengths (~0.3 Hz frame rate); the flow speed acquisition time is ~5 min for a 0.5 mm crosssectional line using single wavelength.
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To validate mPAM, first we studied the MRO2 responses to hyperthermia and cryotherapy, two
common therapeutic techniques. Furthermore, mPAM was used to image melanoma and
glioblastoma longitudinally, demonstrating its capability of early cancer detection.
3.4.1. Methods
Animal model. The nude mouse ear is a good model for validating mPAM because of its
similarity to human skin and lack of motion artifacts [111-113]. Each artery-vein pair (AVP)
feeds a well-defined region while one pair at the base of the ear feeds the entire ear (Fig. 19)
[114, 115]. Consequently, the MRO2 based on each AVP approximates the MRO2 of its supplied
region.

Figure 19. mPAM measurements of oxygen saturation (sO2) and blood flow on four orders of artery‐vein pairs
in the mouse ear. (a) sO2 mapping from two measurements at 584 nm and 590 nm. Four different orders of
artery‐vein pairs are labeled. Scale bar: 125 µm. (b) Profiles of blood flow speed across vessels of different
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orders measured along the dashed lines in (a) on the basis of PA bandwidth broadening at 584 nm. Generally,
the flow speed decreases from the proximal order to the distal order. However, it also depends on the vessel
diameter as a result of the conservation of total flow. Solid circles: experimental data; red curves: fit. (c) Mean
sO2 versus the vessel order, quantified along the centerline of each vessel. The sO2 values in both the arteries
and veins change slightly with the vessel order, especially at distal branches. This is probably due to oxygen
diffusion between the arteries and veins, and the inhomogeneous MRO2. (d) Blood flow rate (in µl/min)
versus the vessel order, quantified from the flow speed profiles and vessel diameters. Blood flow in both
arteries and veins decreases from the proximal order to the distal order, and is conserved between the artery
and vein of the same order. The blood fed by the artery is mostly drained by the corresponding vein of the
same order. V: vein; A: artery.

Hyperthermia experimental protocol
In the hyperthermia study, the animal’s temperature was regulated by adjusting the water
temperature in the heating pad placed underneath its abdomen. The water was circulated by a
water-bath system (ISOTEMP 9100, Fisher Scientific). A cotton layer between the heating pad
and the animal skin buffered and homogenized the temperature change and thus protected the
animal from burns. The room temperature was kept at 23 ºC. The animal’s skin temperature
(SKT) was monitored on the dorsal pelvis by an attached electronic thermometer (Radio Shack,
Cat. No. 63-854). Before the experiment, the SKT was adjusted to 31 ºC, which was used as the
baseline. The experiment was divided into three periods. The animal was first monitored at
baseline temperature for ~40 min (the resting period), then heated for ~30 min by increasing the
heading pad to 50 ºC (the heating period), and lastly allowed to cool to baseline for ~100 min
(the recovery period). The hemodynamic parameters were simultaneously measured on the
principal artery-vein pair (AVP) using mPAM. Each measurement took ~6 min, and the whole
experiment lasted for ~3 hrs.
Tumor cell culture
B16 mouse melanoma cells were obtained from the Tissue Culture and Support Center at the
Washington University School of Medicine. The cells were maintained in Dulbecco’s modified
Eagle medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 10% FBS and 1% P/S.
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U87 MG human brain glioblastoma cells (HTB-14) were obtained from American Type Cell
Culture (ATCC). The cells were maintained in Eagle’s Minimum Essential Medium (EMEM,
Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS, ATCC) and 1%
penicillin-streptavidin (P/S, Invitrogen). The cultures were performed at 37 °C and 5% CO2, and
the cells were passaged weekly.
Inoculation of tumor cells
In the tumor study, 0.01 ml of suspension containing ~0.5 million B16 melanoma cells or U87
human glioblastoma cells was inoculated into the top skin layer in the left ear of a nude mouse,
using a 0.3 ml syringe with a 29-gauge needle. The injection was usually located near the second
order branch of the principal AVP above the cartilage. The tumor was allowed to grow and
monitored for one to three weeks. A control measurement was performed before the tumor cell
injection (day 0).
Hemodynamics measured by mPAM
The hemodynamic parameters were monitored using mPAM on the principal AVP, which
included vessel diameter, total hemoglobin concentration, oxygen saturation, blood flow
direction, and flow speed.
1. Vessel diameter. The vessel diameter was measured along a cross-section perpendicular
to the vessel centerline. A threshold of two times the noise level was empirically set to
separate the background and vessel. The transverse dimension of the vessel cross-section
was taken as the vessel diameter D, in case the excitation light could not penetrate the
whole vessel in the axial direction. Then the vessel cross-section area was calculated as
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A    D / 2 . Five adjacent cross-sections were measured, and the mean value of the
2

principal vein was used for MRO2 calculation.
2. Total hemoglobin concentration. Since oxy-hemoglobin and deoxy-hemoglobin have the
same absorption coefficient at 584 nm, the PA signal amplitude is proportional to the
total hemoglobin concentration regardless of the oxygen saturation level [116]. On the
basis of a previous study [117], the total hemoglobin concentration was set to be 146.0 g/l
at baseline temperature (the hyperthermia study) and on day 0 (the tumor and cryotherapy
studies). The sequential data sets were calibrated accordingly. The averaged PA signal
amplitude along the centerline of the principal vein was used for calculation.
3. Oxygen saturation. The oxygen saturation (sO2) was measured using laser excitations at
584 nm and 590 nm, respectively [33]. The relative change in molar extinction
coefficient is ~58.4% for oxy-hemoglobin and 17.5% for deoxy-hemoglobin, respectively.
Because the vessels studied here were big enough (> 50 μm) and the laser pulse energy
was low (~100 nJ), the difference of penetration depth won’t affect the results much. The
PA signal at each wavelength was normalized with the laser pulse energy, as monitored
by a wavelength-calibrated photodiode. The averaged sO2 along the vessel centerline was
used for MRO2 calculation. The PA image acquired at 584 nm was used as a mask on the
sO2 image to remove the background noise.
4. Blood flow direction. The blood flow direction was measured on the basis of
photoacoustic bandwidth broadening with bidirectional motor scanning at 584 nm [80].
The laser repetition rate was 3 KHz, and the scanning step size was 0.625 µm. We used
64 sequential A-lines to calculate the bandwidth broadening. If the blood flow had a
positive projection along the positive scanning direction, we defined it as a positive flow,
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and vice versa. The mPAM image acquired at 584 nm was used as a mask on the flow
image to remove the background noise.
5. Blood flow speed. To better estimate the flow speed, M-mode imaging at 584 nm was
used to measure the bandwidth broadening across the vessel. The laser repetition rate was
3 KHz, and 3200 A-lines were acquired at each position. The flow speed at each position
was calculated on the basis of the bandwidth broadening. The average amplitude of the
PA signal at each position was used as a mask on the speed profile to remove the
background noise. The mean flow speed of the principal vein was used for MRO2
calculation.
Melanoma volume estimation using mPAM
After data acquisition, the PA signal amplitude acquired at each optical wavelength was
extracted through the Hilbert transformation. The tumor region was then separated from the
surrounding blood vessels according to the mPAM image acquired at 605 nm, where melanin has
much stronger absorption than blood. A threshold of 20% of the maximum signal amplitude was
set to segment the tumor. Since it was challenging to penetrate through the whole tumor due to
the high absorption of melanin, a 3D envelope of the tumor region was obtained from the surface
signal instead. The volume of the tumor was then calculated by integrating the corresponding
voxels enclosed by the envelope. All the image processing was conducted using the MATLAB
Image Processing Toolbox (R2008a, MathWorks).
Fitting for the profile of blood flow speed
A theoretical model was used to fit the profile of the blood flow speed across the vessel [86],
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(11)

Here, x is the transverse location; x0 is the vessel center; R is the vessel radius; vmax is the flow
speed at the vessel center; and n is the power index that characterizes the flow profile (e.g., n
=2 for laminar flow). While x0 and R can be measured directly from the mPAM images of the
vessel structure, vmax and n are the unknown parameters to fit for.

Statistical analysis
Quantitative data was expressed as mean ± s.e.m. The statistical test is a paired Student’s t-test
(two-tailed with unequal variance), compared with the baseline levels (hyperthermia and
cryotherapy studies) or day 0 (tumor studies). We considered a p-value less than 0.05 to be
statistically significant.

3.4.2. Results
MRO2 quantification under normothermia
As an example, we measured the MRO2 of a mouse ear under normothermia. The animal’s
temperature was regulated with a heating pad placed under its abdomen (skin temperature: 31
˚C), a volumetric image was acquired using mPAM at 584 nm by scanning a 10 mm × 8 mm area
containing the principal AVP (Fig. 20a). Because 584 nm is an isosbestic wavelength for
hemoglobin, this image maps the concentration of total hemoglobin regardless of the oxygen
saturation level. In addition, it measures the diameters of the principal AVP (artery: ~65 µm;
vein: ~116 µm). Two PAM images acquired at 584 nm and 590 nm were then used to calculate
sO2 (Fig. 20b) [74]. The vessels with high sO2 values (>90%) are classified as arteries, whereas
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the vessels with low sO2 values (60–80%) are veins. The blood flow velocity was measured at
584 nm using bi-directional scanning with a laser repetition rate of 3 KHz and a motor step size
of 0.625 µm (Fig. 20c). The profile of flow speed across the principal AVP is shown in Fig. 20d.
The artery and the vein have a mean flow speed of 5.5 mm/s and 1.8 mm/s, respectively, and the
speed profiles are both approximately parabolic [86]. The weight of the mouse ear was computed
by its volume in the 3D PA image, where the average specific weight was assumed to be 1.0
g/ml [118]. From these measurements, the MRO2 of the mouse ear was estimated to be 0.23
ml/100 g/min, which agrees with the data previously measured in humans [92].

Figure 20. Label‐free quantification of metabolic rate of oxygen (MRO2) in vivo. (a) mPAM image of the total
concentration of hemoglobin (CHb). Scale bar: 500 µm. (b) mPAM image of the oxygen saturation of
hemoglobin (sO2) in the area indicated by the dashed box in (a). Scale bar: 125 µm. (c) mPAM image of blood
flow in the area indicated by the dashed box in (b). Red arrow: positive scanning direction; blue arrow:
negative scanning direction. Positive velocity: upward flow. Scale bar: 125 µm. (d) Profile of blood flow speed
across the dashed line in (c).

Change in MRO2 induced by systemic hyperthermia
Hyperthermia has been clinically used for cancer treatment [119]. To measure MRO2 during
hyperthermia, the mouse’s skin temperature was elevated to 42 ºC (Fig. 21a). Hemodynamics
were monitored on the principal AVP. The vessel diameter started increasing at the beginning of
the heating period (Fig. 21b), and reached a maximum by the end of the heating period. The total
hemoglobin concentration of the principal AVP kept increasing after the heating started, and
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plateaued when the temperature returned to the baseline (Fig. 21c). This cumulative effect was
due to a decrease in blood plasma volume resulting from water loss during hyperthermia [120].
From the change in sO2 (Fig. 21d), we found that the oxygen extraction fraction (OEF, defined
as

sO

2in

sO2out  / sO2in and represents the fraction of O2 molecules that cross the capillary wall)

decreased by 12% over the heating period and eventually recovered to 99% of the resting level
(Fig. 21f). The measurements of flow speed in the arteries during the heating were saturated
because of the limited maximum measurable speed of the system (Fig. 21e). From the
measurements on the principal veins, we found the volumetric flow rate of blood entering the ear
increased by 45%. Increased cardiac output and redistribution of blood to the skin are two major
reasons for vessel dilation and faster blood flow, which help accelerate heat exchange with the
environment [119, 121]. Note that the vessel diameter, sO2, and blood flow speed reach the
peaks approximately simultaneously.
The MRO2 of the mouse ear, as computed from the hemodynamic changes, increased by 28%
over the heating period (Fig. 21f), which indicated elevated oxygen metabolism during
hyperthermia in response to an increased rate of enzymatic reactions [122]. This finding can
potentially elucidate another possible mechanism for cell death induced by hyperthermia. When
normal cells encounter such an increased metabolism, increased blood flow provides more
nutrients. By contrast, cancer cells could be damaged owing to inadequate blood circulation.
Therefore, hyperthermia may kill cancer cells by both protein denaturation and cell starvation
due to heating.
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Figure 21. mPAM measurement of hemodynamic responses to a hyperthermic challenge (red bars). Relative
changes of (a) the skin temperature, (b) vessel diameter, (c) total hemoglobin concentration, (d) oxygen
saturation (sO2), (e) blood flow speed, and (f) oxygen extraction fraction (OEF) and metabolic rate of oxygen
(MRO2). Statistics: paired Student’s t‐test. * p < 0.05, ** p < 0.01, n = 3. Data are presented as means ± s.e.m.
The baseline values are (a) temperature: 31.0 ± 0.4 ºC, (b) vessel diameters: 92.5 ± 10.5 µm (vein) and 47.5 ±
8.5 µm (vein), (c) CHb: 146.3 ± 18.1 g/l (vein) and 148.5 ± 14.0 g/l (artery), (d) sO2: 0.70 ± 0.08 (vein) and 0.94
± 0.04 (artery), (e) flow speeds: 1.3 ± 0.4 mm/s (vein) and 5.1± 0.8 mm/s (artery), (f) 0.26 ± 0.13 (OEF) and
0.30 ± 0.09 ml/100 g/min (MRO2).

Change in MRO2 induced by local cryotherapy
Cryotherapy has been found effective for treating cancer and other diseases by forming ice
crystals inside cells [123, 124]. Here, we applied liquid nitrogen to the mouse ear surface for 10
seconds via a 1 mm diameter cryo-probe, and monitored the hemodynamics of the treated area
(Figs. 22a-b). An untreated neighboring area of the same ear was also monitored as a control.
Right after the treatment, a global reflective vasodilatation was observed on both the treated and
control areas, which was accompanied by an increase in blood flow and a decrease in OEF.
While the MRO2 of the control area remained unchanged statistically, the MRO2 of the treated
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area decreased by 56% due to the induced cell death. Therefore, mPAM can be used to evaluate
the efficacy of cryotherapy.

Figure 22. mPAM monitoring of hemodynamic responses after cryotherapy. (a) mPAM vasculature images
acquired in different phases before and after the application of liquid nitrogen. The treated area is indicated
by cyan dashed circles. Scale bar: 500 µm. (b) mPAM images of oxygen saturation (sO2) in the artery‐vein pair
[cyan dashed box in (a)] that supports the treated area. Scale bar: 125 µm.

Within one month after the treatment, while all the parameters of the control area monotonically
recovered to the baseline, the physiological progress of the treated area occurred in phases (Figs.
23a-c). Within three days following the reflective vasodilatation, blood flow and OEF trended
toward the baseline, but MRO2 remained at a low level due to cell necrosis. Starting from day 5,
inflammation was clearly observed, which was triggered by the immune system and was helpful
for both dead cell clearance and new cell growth. Although the OEF continued to decrease due to
the increased flow speed [101], the MRO2 of the treated area eventually returned to the baseline,
reflecting improved tissue viability. One month later, the inflammation nearly ended, and all the
parameters had recovered almost to the baseline.
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Figure 23. mPAM quantification of blood flow rate (a), oxygen extraction fraction (OEF) (b) and metabolic
rate of oxygen (MRO2) (c) within 30 days after the treatment. A neighboring area close to the treated region
was monitored as a control. Statistics: paired Student’s t‐test. * p < 0.05, ** p < 0.01, *** p < 0.001, n = 4. Data
are presented as means ± s.e.m. Baseline flow rates: 0.72 ± 0.12 µl/min (treated) and 0.44 ± 0.15 µl/min
(control); baseline OEF: 0.35 ± 0.04 (treated) and 0.31 ± 0.05 (control); baseline MRO2: 0.30 ± 0.06 ml/100
g/min (treated) and 0.25 ± 0.07 ml/100 g/min (control). BL: baseline.

This study shows that each physiological phase after cryotherapy imparts its signature on the
local MRO2. The common belief is that inflammation triggered by the immune response further
helps kill tumor cells [125]. However, our results show that the increased blood flow rate during
inflammation may assist the survival of residual tumor cells by providing more nutrients and thus
recovering the MRO2 level.

Early cancer detection by measuring tumor‐induced change in MRO2
The third demonstration of mPAM is early cancer detection by measuring MRO2. The
hemodynamics of the mouse ear were longitudinally monitored after the injection of B16
melanoma cells (Fig. 24a). On day 7, vessel dilation appeared around the tumor site as shown in
Fig. 24b and Fig. 25b. The volumetric blood flow rate increased by 1.5 fold (Fig. 24c and Fig.
25e). These changes are important to ensure the supply of oxygen and nutrients to the rapidly
growing tumor, and to provide routes for tumor cell metastasis [126]. The overall OEF of the
tumor region decreased by 43% (Fig. 24c and Fig. 25f) due to the increased blood flow [101].
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Figure 24. mPAM detection of early‐stage melanoma by measuring metabolic rate of oxygen (MRO2). (a)
White‐light photographs of a representative mouse ear before (day 0), 3 days and 7 days after the
xenotransplantation of B16 melanoma tumor cells. Scale bar: 1 mm. (b) mPAM images of the tumor region
[dashed boxes in (a)] at 584 nm. z is coded by colors: blue (superficial) to red (deep). Scale bar: 125 µm. (c)
mPAM quantification of blood flow rate, oxygen extraction fraction (OEF) and metabolic rate of oxygen (MRO2)
before (day 0), 3 days and 7 days after the tumor xenotransplantation, normalized by the values of day 0
(flow rate: 1.77 ± 0.50 µl/min; OEF: 0.31 ± 0.04; MRO2: 0.38 ± 0.03 ml/100 g/min). Statistics: paired Student’s
t‐test. ** p < 0.01, *** p < 0.001, n = 5. Data are presented as means ± s.e.m. MT: melanoma tumor; VD:
vasodilatation.

The vasculature and melanoma were differentiated according to their different absorption spectra
using dual-wavelength excitation at 584 nm and 605 nm, and thus the tumor volume could be
estimated (Fig. 26).
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Figure 25. mPAM measurements in absolute units of (a) ear weight, (b) vessel diameter, (c) total hemoglobin
concentration, (d) oxygen saturation of hemoglobin (sO2), (e) volumetric blood flow rate, (f) oxygen
extraction fraction (OEF), (g) rate of O2 consumption in µl/min, and (h) metabolic rate of oxygen (MRO2) in
ml/100 g/min up to 21 days after tumor inoculation. Statistics: paired Student’s t‐test. * p < 0.05, ** p < 0.01,
*** p < 0.001, n = 3. Data are presented as means ± s.e.m.

The hypermetabolism of melanoma was reflected by 36% increase in MRO2 (Fig. 24c), which
proves the early cancer detection capability of mPAM. The presence of the melanoma was
confirmed by histology (Fig. 27). However, the melanoma was hyperoxic instead of hypoxic in
the early stage (Fig. 25d). On day 14, MRO2 dropped to the baseline level and continued to
decrease (Fig. 25h), even though the total oxygen consumption rate increased steadily (Fig. 25g).
There are two possible reasons for the final decline in MRO2. On one hand, a tumor changes to
anaerobic respiration instead of aerobic respiration when it grows too quickly to get sufficient
oxygen [92]; on the other hand, when the tumor grows too large, the tumor core dies due to a
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decrease in available nutrients (necrosis). The necrotic tumor core does not consume oxygen but
increases tumor weight (Fig. 25a), which decreases the MRO2 [127].

Figure 26. mPAM differentiation of blood vessels and melanoma. (a) White‐light photographs of a
representative mouse ear before and 3 days after the xenotransplantation of B16 melanoma cells. Scale bar: 1
mm. (b) Composite mPAM images of blood vessels (in red) and melanoma (in brown). The two are
differentiated by using dual‐wavelength excitation at 584 nm and 605 nm. CHb: total hemoglobin
concentration. CM: melanin concentration. Scale bar: 250 µm. MT: melanoma tumor.

Besides melanoma, we also studied U87 human glioblastoma (Fig. 28a), which is more
transparent; thus, its intratumoral vasculature can be better visualized. On day 7, angiogenesis
was observed within the tumor region (Fig. 28b), and the sO2 of the draining vein was found to
be increased, indirectly indicating early-stage tumor hyperoxia (Fig. 28c). The presence of the
glioblastoma was confirmed by histology (Fig. 29). While the increase in blood supply for the
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glioblastoma was comparable with that for the melanoma, the OEF showed a decrease by 24%
instead of 43% (Fig. 28d). We observed a 100% increase in MRO2 instead of 36% for the
melanoma, which indicated a stronger hypermetabolism at the early stage of glioblastoma.
However, characteristic of early-stage cancer [128] , such hypermetabolism did not lead to tumor
hypoxia. In fact, the sO2 in the intratumoral vasculature was even higher than that of the
surrounding normal tissue, directly indicating early-stage tumor hyperoxia (Fig. 28e and Fig. 30).
The increase in sO2 actually caused the decrease in OEF in the tumor. This observation suggests
that hypoxia-based diagnosis may not apply to early-stage cancer [129].

Figure 27. Histological validation of melanoma detection. (a) mPAM image of a mouse ear bearing a B16
melanoma tumor acquired on day 7. z is coded by colors: blue (superficial) to red (deep). Scale bar: 300 μm.
(b) Images of H&E stained tissue slices cut approximately across the tumor area (top) and non‐tumor area
(bottom). Scale bar: 150 μm. MT: melanoma tumor.

53

Figure 28. mPAM detection of early‐stage glioblastoma by measuring metabolic rate of oxygen (MRO2). (a)
White‐light photographs of a representative mouse ear before (day 0) and 7 days after the
xenotransplantation of U87 glioblastoma tumor cells. Scale bar: 2 mm. (b) mPAM images of microvasculature
in the tumor region [dashed boxes in (a)] at 584 nm. z is coded by colors: blue (superficial) to red (deep).
Scale bar: 250 µm. (c) mPAM images of oxygen saturation (sO2) in the artery‐vein pair [double arrows in (b)]
that supports the tumor region acquired on day 0 and day 7. Scale bar: 100 µm. (d) mPAM quantification of
volumetric blood flow rate, oxygen extraction fraction (OEF) and MRO2 7 days after the tumor
xenotransplantation, normalized by the values of day 0 (flow rate: 1.03 ± 0.41 µl/min; OEF: 0.27 ± 0.03; MRO2:
0.31 ± 0.09 ml/100 g/min). (e) Comparison of the averaged sO2 values in the intra‐ and extra‐tumoral
vasculatures. Statistics: paired Student’s t‐test. * p < 0.05, ** p < 0.01, n = 5. Data are presented as means ±
s.e.m. GT: glioblastoma tumor.
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Figure 29. Histological validation of glioblastoma detection. (a) mPAM image of a mouse ear bearing a U87
glioblastoma tumor acquired on day 7. z is coded by colors: blue (superficial) to red (deep). Scale bar: 250 μm.
(b) Images of H&E stained tissue slices cut approximately across the tumor area (left) and non‐tumor area
(right). Scale bar: 150 μm. GT: glioblastoma tumor.

3.4.3. Conclusions and discussion
The observations presented here demonstrate the power of mPAM as the only noninvasive labelfree imaging modality that can measure all the parameters required for the quantification of
MRO2 in absolute units. Whereas MRO2 is the ultimate measure of oxygen metabolism, OEF and
sO2 can be misleading partial measures. Unlike commonly believed, a decrease in OEF or an
increase in sO2 does not necessarily indicate a decrease in MRO2. Strikingly, we found earlystage cancer to be hyperoxic instead of hypoxic despite the hypermetabolism.
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Figure 30. Label‐free mPAM of hypermetabolism and hyperoxia of early stage cancer. (a) Photograph of a
mouse ear bearing a xenographed glioblastoma on Day 7. Scale bar: 2 mm. (b) mPAM image of the vasculature
of the mouse ear. The depth is color coded: blue (superficial) to red (deep). Scale bar: 200 μm. (c) mPAM
image of the sO2 of the tumor region in (b). It is clearly shown that the tumor region was hyperoxic. Scale bar:
200 μm.

mPAM can non-invasively measure anatomical, functional, and fluid-dynamic information at the
resolution of small vessels, making it possible for MRO2 quantification in microenvironments.
MRO2-based early cancer detection and evaluation of its treatment are highly desirable. mPAM
has also various other prospective applications related to MRO2. First, its high spatial resolution
is essential for micro-hemodynamic studies, such as monitoring of local hemorrhage caused by
mini-strokes. Second, its high sensitivity is critical for studies concerning small metabolic
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changes, such as monitoring of neuro-vascular coupling in response to physiological challenges.
Third, its potentially real-time imaging through fast optical scanning or ultrasonic-array detection
is important for studies involving short transition times between physiological states, e.g.,
monitoring of epileptic seizures. Finally, its high spatial scalability enables us to correlate
microscopic and macroscopic studies—e.g., monitoring of local neuron firing and overall brain
activity—based on the same contrast. Overall, mPAM has strong potential for the study of
metabolism in cancer and other metabolic diseases.

4. Improvements in photoacoustic microscopy
While AR-PAM has achieved so far tens of micrometers resolution with a penetration depth up
to 3 mm in tissue [33], OR-PAM focuses on superficial imaging (up to ~1 mm in tissue) with at
least capillary level resolution [7]. Recently, the imaging performance of OR-PAM has been
significantly improved in terms of spatial resolution and imaging speed. By using a waterimmersion optical objective with a 1.23 numerical aperture (NA), a 220 nm lateral resolution at
532 nm wavelength has been achieved [130]. Meanwhile, by using a fast voice-coil scanner, the
sectional imaging speed of OR-PAM has been pushed to 40 Hz over a 1 mm scanning range
[131]. To further expand the coverage of OR-PAM and push its commercialization, numerous
efforts have been invested to improve its performances. Here, we are going to describe two
aspects of the improvements of OR-PAM, including extending its imaging depth by double
illumination and speeding up its imaging speed by using a fast scanning MEMS mirror.

4.1. Double illumination photoacoustic microscopy
So far, the penetration depth of OR-PAM is still restricted to one transport mean free path due to
the strong optical scattering in tissue. Moreover, the strong absorption of hemoglobin in the
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visible spectral range further reduces the 1/e penetration depth to less than 50 m in blood
vessels, which may cause shallower vessels to shadow deeper vessels. This penetration limitation
applies to both reflection-mode and transmission-mode OR-PAM. Only a layer of tissue on the
optical illumination can be imaged [32, 36, 130, 132]. By illuminating light from both the top
and bottom sides of the sample, we have developed a double-illumination PAM (DI-PAM) to
improve the penetration depth to ~2 mm in thin biological tissue. At the same time, the optical
focal zone is expanded to ~260 µm.

4.1.1. Methods
In DI-PAM (Figure 1), a Nd:YVO4 laser (Elforlight, SPOT) generates 1.5 ns pulses at a 532 nm
wavelength. The pulses are reshaped by an iris (ID25SS, Thorlabs) and attenuated by a neutral
density filter (NDC-50C-2M, Thorlabs). The attenuated beam is then split into two sub-beams
(top and bottom) by a 50/50 beam splitter (BSW04, Thorlabs). The top beam is focused by a
condenser lens (LA1131, Thorlabs) before passing through a 50 m pinhole (P50C, Thorlabs)
for further spatial filtering. The filtered beam is then focused by an optical objective (AC127050-A, Thorlabs. NA: 0.1 in air) into the sample from the top. A beam combiner composed of a
thin layer of silicone oil sandwiched by a right-angle prism (NT32-545, EdmundOptics) and a
rhomboid prism (NT49-419, EdmundOptics) provides acoustic-optical coaxial alignment. The
resultant photoacoustic waves are detected by an ultrasonic transducer (V214-BB-RM, OlympusNDT) with a central frequency of 50 MHz. An acoustic lens with an NA of 0.5 is ground into the
bottom of the rhomboid prism to provide an acoustic focal diameter of 30 μm. An optical
correction lens is attached to the top of the beam combiner to correct the aberration. The acoustic
lens is submerged in a water-tank for ultrasound coupling. The bottom beam duplicates the same
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path as the top beam, except that it is directly focused into the sample from the bottom without
going through the beam combiner and water tank.
As shown in the inset of Fig. 31, by carefully adjusting the positions of two objectives, we
achieved a co-axial configuration of the two optical foci and the acoustic focus. To best expand
the optical focal zone, the top and bottom optical foci are both approximately one Rayleigh range
apart from the acoustic focus. Volumetric imaging is acquired by two-dimensional raster
scanning of the sample. While the lateral resolution is defined by the optical focus, the depth
resolution is determined by the temporal resolution of the acoustic detection. An eyepiece is
added to the bottom beam path to view the imaging region through the reverse path of the
illumination. A photodiode is also added to monitor the fluctuations of the laser pulse intensity.

Figure 31. . Schematic of DI-PAM. d1,2; Rayleigh range. ND, neutral density filter; BS, beam-splitter; ConL,
condenser lens; PH, pinhole; M, mirror; OL, objective lens; CorL, correction lens; RAP, right-angle prism; SOL,
silicone oil layer; RhP, rhomboid prism; UT, ultrasonic transducer; WT, water tank; SH, sample holder; MS,
motor scanner; EP, eyepiece; PD, photodiode.
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4.1.2. Results
Phantom study
To measure the lateral resolution of the DI-PAM system, a sharp ink edge was imaged in water
at varied depths while the optical focus was fixed. From the edge spread function, the full width
half maximum of the line spread function was computed to determine the lateral resolution. As a
comparison, the lateral resolution under either top or bottom illumination was also quantified
using the same protocol. The measured results were fitted using the theoretical model for a
Gaussian beam
the focal diameter,

, where
is the wavelength and

is the lateral resolution at depth ,

is the focal depth. While

is known,

is

and

are the unknown parameters to fit for. As shown in Fig. 32a, the top illumination gives a focal
diameter of 2.3 µm with a focal zone of 100 µm. Here, focal zone is defined as the range of
depths over which the system maintains a lateral resolution no worse than √2

. Similarly, the

bottom illumination gives a focal diameter of 2.9 µm, with a focal zone of 170 µm. The two foci
are 160 µm apart. The top illumination has a tighter focusing due to the addition of the correction
lens which gives an effective NA of 0.133 in water, while the bottom illumination has an NA of
0.1 in air. As can be seen in Fig. 32b, under double illumination, the lateral resolution has a ‘W’
shape distribution along the depth, which is determined by the overall light intensity of the two
beams. The two valleys of the ‘W’ distribution are 2.3 µm and 2.9 µm in lateral resolution,
which equal to the top and bottom focal diameters, respectively. The effective focal zone is
expanded to 260 µm, which is the sum of the focal zones of the two valleys (100 µm and 160 µm,
respectively). Thus, by increasing the focal zone by 160 µm over the top illumination or 90 µm
over the bottom illumination, DI-PAM maintains the lateral resolution over a longer depth range.
60

Top illumination
Bottom illumination

10
8
6
4
2
300

400

500

600

700

800

Relative axial position z (µm)

(b)

Lateral resolution (µm)

Lateral resolution (µm)

(a)

10

Double illumination

8
6
4
2
300

400

500

600

700

800

Relative axial position z (µm)

Figure 32. Lateral resolution as a function of the axial position relative to the starting depth of dataacquisition, under top, bottom and double illumination illuminations, respectively. Solid curves: theoretical
fitting.

Figure 33. Penetration depth of double‐illumination PAM. (a) Side-view DI-PAM images of the human hair
inside the chicken tissue under three illuminations. Scale bar: 200 µm. (b) Volumetric rendering of the human
hair imaged by DI-PAM.

To measure the penetration depth of the DI-PAM system, a black human hair was obliquely
embedded in a 2-mm-thick piece of fresh chicken breast tissue. The two ends of the hair tightly
pressed against the top and bottom surfaces of the tissue, and served as landmarks of the tissue
boundaries. The top and bottom illuminations both had a pulse energy of 80 nJ. As shown in Fig.
33a, while either single illumination can image only the top (1.16 mm) or bottom (1.25 mm) part
of the hair, DI-PAM can clearly image the whole hair Fig. 33b, demonstrating a penetration
depth of at least ~2 mm in biological tissue.
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Animal study
The improved system performance enables DI-PAM to image deeper vasculature while
maintaining capillary level lateral resolution. The mouse ear was chosen for a first demonstration.
The ear of a 12-week-old nude mouse (Hsd:Athymic Nude-FoxnlNU, Harlan) is composed of a
layer of auricular cartilage sandwiched by two layers of skin tissue (Fig. 34d). The ear of our
experimental mouse became much thicker seven days after the injection of ~106 U87
glioblastoma cells (Fig. 34c). A 10×15 mm2 area including the tumor region was sequentially
imaged under top, bottom and double illuminations. In Fig. 34a, the depth-encoded maximum
amplitude projection (MAP) images show that only the top layer vessels (shown in green) or
bottom layer vessels (shown in red) can be well imaged under top or bottom illumination,
respectively. Optical shadowing is the key reason. Although some big vessels from the other
layer are discernable, they are very much blurred due to the degraded lateral resolution. In
contrast, DI-PAM can clearly image both layers of vasculature without shadowing or blurring.
The side-view MAP images in Fig. 34b further demonstrate the improvements of DI-PAM in
penetration depth and focal zone, imaging through the whole ear with a thickness more than 1
mm.

62

Figure 34. DI-PAM of mouse ear in vivo. (a) Top-view depth-encoded DI-PAM images of the right ear of a nude
mouse bearing a U87 glioblastoma tumor, under top (TI), bottom (BI) and double (DI) illuminations,
respectively. z is coded from green (superficial) to red (deep). Scale bar: 500 μm. (b) Side-view DI-PAM images
under three illuminations. CHb, total hemoglobin concentration. Scale bar: 500 μm. (c) Photograph of the
mouse ear. The imaged area is indicated by the blue dashed box. Scale bar: 2 mm. (d) Histology image of H&E
stained tissue slice across the mouse ear. AC; auricular cartilage. Arrowheads; blood vessels. Scale bar: 100
μm.

In a second demonstration of DI-PAM, we imaged the vascular network surrounding the small
intestine of a living black mouse (C57BL/6Hsd, Harlan), which is of interest in embryonic
development and sepsis studies [133, 134]. After surgical exposure, part of the small intestine
was gently pulled out and placed on the sample holder for DI-PAM imaging. The high vessel
density on one side of the intestine would prevent imaging the other side by single-illumination
PAM systems (Fig. 35e-f). In contrast, DI-PAM can obtain complete cross-sectional images of
the intestine that is close to 2 mm in diameter (Fig. 35a-b). The depth-encoded MAP image
shows a dense mesenteric vascular network, where the vessels from the top side were colored in
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green and those from bottom side in red (Fig. 35a). The side-view MAP image of the section
indicated by the dashed box in Fig. 35a appears to be a closed loop (Fig. 35b). The villi on the
lumen of the intestine are also clearly resolved (Fig. 35c).

Figure 35. DI-PAM of the small intestine of a C57BL/6 mouse in vivo. (a) Top-view depth-encoded DI-PAM
image of the small intestine under double illumination. Scale bar: 500 μm. (b) Side-view DI-PAM image of the
region indicated by the dashed box in (a). CHb, total hemoglobin concentration. Scale bar: 250 μm. (c) Close-up
of the small region indicated by the dashed box in (b). The intestinal villi are indicated by the arrowheads.
Scale bar: 100 μm. (d) Volumetric rendering of the small intestine imaged by DI-PAM. (e) Photograph of the
small intestine after surgical exposure. Scale bar: 1 mm. (f) Histology image of H&E stained cross-section of
the small intestine. Arrowheads; blood vessels. Scale bar: 200 μm.

4.1.3. Conclusions and discussion
In conclusion, we have developed double-illumination PAM, which offers improved penetration
depth and expanded focal zone. Compared with traditional reflection or transmission mode ORPAM, the penetration depth has been improved to at least 2 mm in biological tissue. In addition,
the focal zone has been improved to 260 m, with a lateral resolution no worse than 4 m. Deep
microscopy of microvascular anatomy in a mouse ear and small intestine was performed.
Although not demonstrated here, DI-PAM is intrinsically ready for label-free measurements of
oxygen saturation, blood flow, and oxygen metabolism.
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Simply doubling the incident light intensity for single illumination OR-PAM can also increase
the penetration depth. However, the resultant improvement is not equivalent to that provided by
DI-PAM. First, doubling incident light will not result in doubling of the penetration depth, since
the attenuation of light by tissue is exponential rather than linear. Second, in DI-PAM, the light
intensity on the tissue surface was 22 mJ/cm2 for both top and bottom illuminations, which is
still close to the American National Standards Institute (ANSI) safety limit (20 mJ/cm2 in the
visible spectral region). However, simply doubling the light intensity for single illumination (44
mJ/cm2) will beak the ANSI limit and thus increase the risk of damaging tissue.
The focal zone of single illumination OR-PAM can also be expanded by depth scanning and
stacking the data sets together. However, this is not equivalent to the improvement due to DIPAM. First, strong tissue scattering would degrade the lateral resolution as the focal position
deepens. Second, the imaging time would be increased by depth scanning. In contrast, DI-PAM
expands the focal zone without sacrificing lateral resolution and imaging speed.

4.2. MEMS scanning mirror based fast scanning photoacoustic microscopy
As all living biological systems are dynamic, it is also important to develop fast-scanning ORPAM systems. Several scanning mechanisms have been reported to push the imaging speed of
OR-PAM. The first type is to optically scan the laser beam within the focal spot of the ultrasonic
transducer [135, 136]. This mechanism, however, suffers from a limited scanning range of ~100
m and inhomogeneous detection sensitivity within the field of view (FOV) [135, 136]. The
second method is to optically scan the laser beam within the detection area of an unfocused
ultrasonic transducer [132, 135]. This method increases the scanning range to a few millimeters,
while reducing the overall detection sensitivity by more than 40 dB. The third form is to
mechanically scan by mounting the whole imaging head on a voice-coil scanner [137]. This
65

design can maintain the confocal alignment and increase the scanning range to a few millimeters,
but over which the scanning speed can reach only ~40 Hz, limited by the mass of the imaging
head. Different fast-scanning methods for PAM imaging are summarized in Table 1.

Table 1: Comparison of fast‐scanning methods
B‐scan rate

Scanning range

(Hz/mm)

(mm)

1

>10

4

Hybrid scanning
Voice‐coil scanning

Scanning methods
Mechanical scanning
Multifocal scanning
(transducer array)

2D optical scanning
(unfocused transducer)
2D optical scanning
(focused transducer)

Transducer

Detection

focusing

homogeneity b

+++

Spherical

+++

[32]

~5

++

Cylindrical

++

[138]

24

~4

++

Cylindrical

++

[139]

40

>5

+++

Spherical

+++

[140]

100

~6

+

Unfocused

+++

[132]

180

<0.1

++

Spherical

+

[135]

SNR

a

a

More plus signs indicate better SNR.

b

More plus signs indicate better homogeneity of the acoustic detection over the scanning range.

Ref

Here, we present a wide-field fast-scanning OR-PAM by using a lab-made water-immersible
MEMS (i.e., microelectromechanical system) scanning mirror (MEMS-OR-PAM). A crosssectional (B-scan) imaging rate of 400 Hz over a 3 mm range has been achieved. By scanning
both the excitation laser beam and resultant acoustic beam, MEMS-OR-PAM maintains confocal
alignment and high detection sensitivity over a large FOV.

4.2.1. Methods
Fig. 36 is a schematic of the MEMS-OR-PAM. The light source is an Nd:YVO4 laser (AOTYVO-100Q, AOT Inc.,) which generates 2 ns pulses at 532 nm with a repetition rate of 100 kHz.
The laser beam is focused by a condenser lens (LA1131, Thorlabs) then spatially filtered by a
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50-μm-diameter pinhole (P50C, Thorlabs). The filtered beam is focused by an optical objective
lens (AC127-050-A, Thorlabs. NA: 0.1 in air). A beam combiner composed of an aluminumcoated prism (NT32-331, Edmund) and an uncoated prism (NT32-330, Edmund) provides
acoustic-optical coaxial alignment. The thin aluminum coating provides optical reflection but
acoustic transmission. The focused laser beam is directed towards the sample surface by the
aluminum coating of the combiner and a MEMS scanning mirror plate. An optical correction
lens attached to the top surface of the combiner corrects the aberration due to the prism. The
resultant photoacoustic waves are reflected by the MEMS scanning mirror and detected by an
ultrasonic transducer (V214-BB-RM, Olympus-NDT), which has a central frequency of 50 MHz
and a -6 dB bandwidth of 66%. An acoustic lens with an NA of 0.25 (NT45-010, Edmund) is
attached to the right surface of the combiner and provides an acoustic focal spot size of ~80 μm
in water. The acoustic NA of this system is chosen to be ~50% less than that of previously
reported OR-PAM systems because fitting the MEMS scanning mirror requires a longer working
distance. The whole imaging head is submerged in a water tank for ultrasound coupling.
Volumetric imaging is provided by fast angular scanning of the MEMS scanning mirror along
the x-axis and step motor scanning of the sample along the y-axis.
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Figure 36. Schematic of MEMS‐OR‐PAM. CL, condenser lens; AC, aluminum coating; AL,

acoustic lens; UT, ultrasonic transducer.
As shown in Fig. 37, the MEMS mirror plate is made of silicon with a gold coating, thus
provides a good condition for reflecting both the optical and acoustic beams. The mirror plate is
supported by two hinges made of high-strength flexible polymer materials, which can resist
surface tension forces in liquids. To actuate the mirror, high efficient electromagnetic force is
generated by a compact inductor coil and a pair of high-strength rare-earth permanent magnets
on the back of the mirror plate. A sinusoidal current applied to the inductor coil generates a
magnetic field with alternating polarity and strength, which drives the mirror plate to oscillate
around the hinges. By controlling the frequency and amplitude of the driving voltage, the
scanning speed and range can be adjusted appropriately.
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Figure 37. MEMS‐scanning mirror. (a‐b) Schematics of the top (a) and side (b) views of the water‐immersible
MEMS scanning mirror. (c) Photograph of a fabricated prototype device. The silicon mirror plate was coated
with a thin gold layer. PF, polymer frame; PM, permanent magnet; AF, actuation force; AH, acrylic holder.

4.2.2. Results
Phantom study
To measure the lateral resolution of the MEMS-OR-PAM system, the edge of a sharp blade was
imaged in water. From the edge spread function, the full width at half maximum of the line
spread function is estimated to be 2.4 µm, which is close to the theoretical, diffraction-limited
focal spot size of the laser beam (2.1 µm) (Fig. 38). The optical focal zone is about 154 µm, in
which the lateral resolution is within 5 µm. The axial resolution was estimated to be ~40 μm
based on the transducer bandwidth and the speed of sound in tissue. Both the lateral and the axial
resolutions decrease with imaging depth due to increasing optical scattering and frequencydependent acoustic attenuation in tissue, respectively.
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Figure 38. Line spread function used to measure the lateral resolution of the system (red circles, the averaged
pixel values; blue line, the Gaussian fit).

The maximum penetration depth of the MEMS-OR-PAM was experimentally quantified by
obliquely inserting a 250-μm-diameter black needle into the leg of an anesthetized nude mouse.
As shown in Fig. 39, after time-gain compensation for the optical and acoustic attenuation, the
system can clearly image the needle down to 1.1 mm beneath the skin surface, which is
comparable to other OR-PAM systems.[36, 137]

Figure 39. MEMS‐OR‐PAM image of a black needle inserted obliquely into the leg of a living mouse. A 1.1 mm
in vivo imaging depth was achieved with time‐gain compensation.
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Different from the linear scanning of traditional OR-PAM systems [32, 36, 137], the angular
scanning of MEMS-OR-PAM results in a curved focal plane with a radius of 7 mm. The
maximum in-focus scanning range is ~3.0 mm along the x-axis. Since raw B-scan images are in
the polar coordinates (Fig. 40a), we converted the data to Cartesian coordinates considering the
scanning geometry and applying a 2D linear interpolation (Fig. 40b). For a uniform black-tape
target, the averaged PA signal amplitude varies less than 5% along the x-axis (Fig. 40b). The
result demonstrates that MEMS-OR-PAM maintains uniform detection sensitivity along the
scanning direction, superior to other fast scanning methods where the confocality is
compromised.

Figure 40. Scanning trace correction of MEMS‐OR‐PAM. (a) Raw B‐scan image of a piece of flat black‐tape in
polar coordinates. The angular scanning of the MEMS mirror introduced the curvature of the imaged target
surface. φ, scanning angle of the MEMS mirror. (b) B‐scan image in Cartesian coordinates converted based on
the scanning geometry and 2D linear interpolation.

Animal study
Red blood cell (RBC) flow in a nude mouse ear was imaged in vivo by MEMS-OR-PAM to
demonstrate its high-speed imaging capability. All experimental animal procedures were carried

71

out in conformity with the laboratory animal protocol approved by the Animal Studies
Committee at Washington University in St. Louis. As shown in Fig. 41, a 2 × 5 mm2 area of the
mouse ear was repeatedly scanned with a volumetric imaging speed of 0.8 Hz (a 2D B-scan rate
of 400 Hz), which is about 400 times faster than the second-generation OR-PAM system and 20
times faster than the most recent voice-coil based OR-PAM scanner for the same scanning range
[36, 137]. The laser pulse energy on the skin surface was measured to be 100 nJ. Since 532 nm is
close to the isosbestic wavelength, the PA signal amplitude reflects the total hemoglobin
concentration regardless of the oxygenation of hemoglobin. The spatial resolution is sufficient
for resolving the capillary beds (Fig. 41), and the imaging speed enables the mapping of the RBC
movements in small vessels. The average signal to noise ratio (SNR) is 36.5 dB, which is about 6
dB less than that of the second-generation OR-PAM system, due to the smaller NA of the
employed acoustic lens [36]. Nevertheless, this SNR is adequate for single RBC imaging [36,
137].

Figure 41. MEMS‐OR‐PAM of blood flow dynamics of the vasculature in a mouse ear. Capillaries were clearly
resolved, and the flow dynamics over a 2 × 5 mm2 area were imaged with a 0.8 Hz volumetric frame rate and
400 Hz B‐scan rate.
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In addition to the RBC flow imaging based on endogenous contrast, intravascular transport of an
exogenous contrast agent was also explored using the system. First, we imaged a 0.6 × 2 mm2
area of a nude mouse ear as a control with laser pulse energy of 100 nJ (Fig. 42a). Then, we
injected carbon particles with ~6 µm diameters (2.5% w/v, carbon glassy spherical powder,
Sigma-Aldrich) into the blood stream of the nude mouse via its tail vein. A 0.3 × 1 mm2 area
which contained a 40-µm-diameter vein was chosen as the region of interest (ROI) for dynamic
imaging. The ROI was repeatedly imaged with a volumetric frame rate of 4 Hz. Lower pulse
energy of 10 nJ was used to image only the particles, which are much more absorbing than
hemoglobin. As shown in Fig. 42b, the average flow speed of the particles in the vein was much
slower than the RBC flow [80]. This is likely due to the larger mass density of the particles (1.46
g/cm3).
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Figure 42. MEMS‐OR‐PAM of flow dynamics of carbon particles. (a) MEMS‐OR‐PAM image of a mouse ear with
a pulse energy of 100 nJ, where the blood vessels were imaged. (b) After the injection of carbon particles via
the tail vein, a smaller region indicated by the dashed box in (a) was monitored with a 4 Hz volumetric frame
rate. The pulse energy was reduced to 10 nJ to image only the particles. The dashed lines are the boundaries
of the vessel containing the flowing particles. A representative particle is indicated by the arrows.

4.2.3. Conclusions and discussion
In summary, we have developed MEMS-OR-PAM that can dramatically improve the imaging
speed while maintaining the confocal alignment of the optical and acoustic beams over a wide
FOV. Conserving the high spatial resolution and imaging sensitivity of traditional OR-PAM
systems, we achieved a B-scan imaging speed of 400 Hz over a 3 mm scanning range, currently
limited by the repetition rate of the employed laser system. The scanning range can be traded off
for imaging speed. A laser system with higher repetition rate or an intensity-modulated
continuous wave laser can further improve the imaging speed. By employing a dual-wavelength
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laser source, MEMS-OR-PAM is intrinsically capable of label-free measurements of oxygen
saturation and oxygen metabolism [39].

PAM can also improve its imaging speed through parallel acoustic detection by ultrasound
transducer arrays. In a multi-focal OR-PAM system, twenty diffraction-limited focal spots are
simultaneously excited, and the resultant PA signals are detected by a 48-element ultrasound
linear array [138]. Limited by the 6:1 multiplexing in data acquisition, the imaging speed is
eventually improved by three to four times, compared with that in conventional single-focus and
single-detector OR-PAM. However, this method needs twentyfold more laser energy than
conventional OR-PAM. Besides, because of the inverse reconstruction of PA images,
reconstruction artifacts due to the limited detection aperture may degrade the image quality.
Currently, it is the laser repetition rate that limits the imaging speed in PAM. Theoretically, realtime (≥30 Hz) volumetric imaging over a 1 × 1 mm2 surface area needs a 5 MHz laser with a
pulse energy of 100 nJ for OR-PAM, or a 50 kHz laser with a pulse energy of 100 J for ARPAM. To avoid interference between PA waves excited by consecutive pulses, it is the acoustic
flight time that limits the ultimate imaging speed. For example, to image a sample with a
thickness of 1 mm, the minimum time interval between consecutive pulses should be 0.67 µs,
which corresponds to a maximum laser repetition rate of 1.5 MHz.

5. Biomedical applications of multi‐contrast photoacoustic microscopy
(tomography)
By offering high-resolution images with unique optical contrast, PAM has so far been applied to
numerous preclinical and human studies, including vascular biology [141-143], oncology [82,
100, 144-149], neurology [74, 150-152], ophthalmology [132, 153-156], dermatology [157-161],
gastroenterology [162-166], and cardiology [35, 167-169]. Here, we are going to introduce
several representative applications. Although photoacoustic computed tomography (PACT) is
not the major topic of this dissertation study, its imaging speed is typically faster than PAM due
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to the parallel acoustic detection by transducer array. Dynamic metabolism of mouse brain was
imaged by PACT in combination with PAM and fluorescence study.

5.1. Immediate alterations in intestinal oxygen saturation and blood flow
following massive small bowel resection as measured by photoacoustic
microscopy
Short gut syndrome is a condition of high morbidity and mortality within the pediatric population
and results primarily from massive intestinal loss. After a massive small bowel resection (SBR)
in both animal models and humans, a critical adaptation response occurs within the remnant
bowel and is characterized by significant increases in villus height and crypt depth, resulting in
increased absorptive mucosal surface area to compensate for the attenuated bowel length [170172]. Angiogenesis has long been recognized as important in states of cellular proliferation [173,
174]. The contribution of villus angiogenesis to intestinal adaptation has recently been
demonstrated. Proangiogenic growth factor supplementation has been shown to enhance
intestinal mucosal growth [175], and inhibition of vascular endothelial growth factor has resulted
in a decreased adaptive response after intestinal loss [176]. Previous study has established an
increased villus capillary density on postoperative day 7 in mice that have undergone massive
SBR [177]. This is preceded on postoperative day 3 by an increase in the gene expression of
proangiogenic chemokine ligand 5 [178]. The exact stimulus for these proangiogenic changes as
well as the acute alterations in intestinal hemodynamics following SBR are presently unknown.
Previous ex vivo studies of intestinal blood flow at late time points after SBR are conflicting.
Studies using intravascular injections of radioactive particles and measurement of radioactivity
from harvested tissue as surrogate markers for blood flow have demonstrated increased blood
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flow following SBR distal to the site of intestinal anastomosis as soon as twenty-four hours
following resection, however, the duration of this hyperemic response has been variable [179181]. In addition, these studies did not measure other parameters of hemodynamics, including
oxygen saturation of hemoglobin (sO2).

No prior studies have measured hemodynamic

parameters within the remnant gut immediately after bowel resection using an in vivo, real time
imaging system with endogenous contrast.
To overcome the limitations of the imaging tools used in prior studies, we sought to determine
the effect of SBR on intestinal hemodynamics using photoacoustic microscopy (PAM), a noninvasive, label-free, high-resolution hybrid imaging modality. With the help of PAM, a better
understanding of the acute hemodynamic changes following SBR may further elucidate a
mechanism for villus angiogenesis and the pathogenesis of intestinal adaptation.

5.1.1. Materials and methods
Experimental design
A protocol for this study was approved by the Washington University Animal Studies
Committee (no 20090275) in accordance with the National Institute of Health laboratory animal
care and use guidelines. Mice underwent either 50% proximal SBR (n=7) or sham (enterotomy
alone) (n=7) procedure as previously described [170]. Photoacoustic microscopy measurements
of the terminal mesenteric arteriole and accompanying vein vessel diameter, blood flow, and
oxygen saturation were obtained at 6 cm proximal to the ileal-cecal junction (ICJ) and at 12 cm
proximal to the ICJ on the serosal surface of the intestine both prior to and immediately
following the procedure.
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Male mice (C57BL/6; Harlan Laboratories, Inc.; Indianapolis, IN) age 8 to 15 weeks were used
in this study. Mice were kept on a 12-hour light-dark cycle and housed in a standard facility. The
mice were given free access to standard rodent food pellets and water up until the time of the
procedure.

Operative technique
Mice underwent 50% proximal SBR or sham (enterotomy alone) as previously reported [170]
with the exception that no reanastamosis was performed. Briefly, a midline laparotomy was
made and the bowel was exposed for photoacoustic measurements. Mice that underwent SBR
had transection of the bowel at 12 cm proximal to the ICJ and at 1 to 2 cm distal to the ligament
of Treitz. The mesentery of the intervening bowel was ligated with a silk tie and the intervening
bowel was removed. In mice that underwent the sham procedure, the bowel was transected only
at 12 cm proximal to the ICJ.

Intestinal sO2 and blood flow measured by photoacoustic microscopy
During the experiment, mice were anesthetized with isoflurane (E-Z Anesthesia, Euthanex) and
placed in a supine position on a heating pad (37 ºC). A midline laparotomy was performed and
the entirety of the small bowel was exposed, The terminal mesenteric artery and accompanying
vein at a point approximately 6 cm and 12 cm proximal to the ICJ were identified. Baseline sO2
was measured at both locations on a 1 × 4 mm2 area containing such vessel pairs at two optical
wavelengths of 532 nm and 560 nm using a previous publish method [88]. Baseline blood flow
speed measurement was then performed at both locations across the proximal end of the vessel in
M-mode using a bandwidth broadening based method [80, 81]. The laser repetition rate was 10
kHz, and 4000 A-lines were acquired at each position. The area of the bowel not being measured
was kept moistened with a normal saline soaked gauze pad. The animal then underwent SBR or
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sham procedure. Following the procedure, the same artery and vein pairs at 6 cm and 12 cm
proximal to the ICJ were imaged with sO2 and blood flow measurements recorded. Following all
measurements the animal was sacrificed via cervical dislocation.

Statistical analysis
All the photoacoustic data processing was conducted using MATLAB (R2008a, MathWorks).
Quantitative values are presented as mean ± SEM. An unpaired Student's t-test was used for
comparisons between all measurements.

A p value less than 0.05 was considered to be

statistically significant. The Sigma Stat statistical package (SPSS, Chicago, IL) was used for all
statistical analyses.

5.1.2. Results
A total of 7 mice underwent the SBR procedure with post-SBR measurements and 7 mice
underwent the sham procedure with post-sham measurements. The presented pre-operative data
(n=7) represents that of the SBR group only as variability in the pre-operative measurements
amongst all animals was minimal. Only data from the measurements recorded at 6 cm proximal
to the ICJ is presented as this mid-remnant bowel location best represents the hemodynamic
changes throughout the entire remnant small bowel. In all cases the 6 cm measurement agreed
with the trend from measurement at the 12 cm proximal to the ICJ location.

Arterial and venous oxygen saturation
Prior to SBR, arterial and venous oxygen saturations (%) were similar (0.98 ± 0.01 arterial pre vs
0.98 ± 0.02 venous pre at 6 cm, p value: 0.70). Immediately following SBR, the arterial oxygen
saturation decreased (0.98 ± 0.01 pre vs 0.84 ± 0.06 post-SBR at 6 cm, p value: <0.05). This
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trend towards decrease in arterial oxygen saturation was also observed following sham (0.98 ±
0.01 pre vs. 0.95 ± 0.01 post-sham at 6 cm, p value: 0.06; Fig. 43a).

Figure 43. Oxygen saturation (sO2) of the terminal mesenteric arteriole (a) and accompanying vein (b) pre‐
operatively, post‐sham (bowel transection alone), and post‐SBR at a location 6 cm from the ileal‐cecal
junction. Asterisk indicates p < 0.05 as compared to pre‐op (pre‐op vs sham and pre‐op vs SBR). Number
sign indicates p < 0.05 sham vs SBR.

Venous oxygen saturation dramatically decreased immediately following SBR (0.98 ± 0.02 pre
vs 0.66 ± 0.05 post-SBR at 6 cm, p value: <0.001). This decrease in venous oxygen saturation
was also observed to a lesser degree following sham (0.98 ± 0.02 pre vs 0.86 ± 0.02 post-sham at
6 cm, p value: < 0.001, Fig. 43b).The difference between arterial and venous oxygen saturation
post-SBR and post-sham was statistically significant, with the venous oxygen saturation
decreasing to a greater extent than the arterial (p value: <0.05). The pronounced difference in
arterial and venous oxygen saturation pre-op and post-SBR are demonstrated in Fig. 44.
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Figure 44. Photoacoustic microscopy images of intestinal microvascular structure and arterial and venous
oxygen saturation (sO2) pre‐operatively and post‐SBR.

Tissue oxygen extraction



Tissue oxygen extraction fraction (OEF) is defined as sO2

artery

artery
 sOvein
and represents
2  / sO2

the fraction of O2 molecules that cross the capillary wall. We found that OEF dramatically
increased post-SBR (0.01 ± 0.01 pre vs 0.21 ± 0.04 post-SBR at 6 cm, p value: < 0.001). OEF
also increased post-sham (0.01 +/- 0.01 pre vs 0.09 +/- 0.02 post-sham at 6 cm, p value: < 0.05);
however, the increase in OEF post-SBR was significantly greater than post-sham (0.21 ± 0.04
post-SBR vs 0.09 ± 0.02 post-sham, p value: < 0.05, Fig. 45).

81

Figure 45. Tissue oxygen utilization pre‐operatively, post‐sham, and post‐SBR at a location 6 cm from the
ileal‐cecal junction as calculated by the oxygen extraction fraction. Asterisk indicates p < 0.05 as compared to
pre‐op (pre‐op vs sham and pre‐op vs SBR). Number sign indicates p < 0.05 sham vs SBR.

Arterial and venous blood flow
Following SBR, the arterial blood flow decreased (7.6 ± 1.5 mm/s arterial pre vs 2.6 ± 0.55 mm/s
post-SBR at 6 cm, p value: < 0.05). No change in arterial blood flow was observed in the sham
group (7.6 ± 1.5 mm/s arterial pre vs 7.7 ± 0.6 mm/s post-sham, p value: 0.93) (Fig. 46a).
Venous blood flow also decreased following SBR (4.0 ± 0.7 mm/s venous pre vs 1.6 ± 0.5 mm/s
venous post-SBR at 6 cm, p value: < 0.05). No change in venous blood flow was observed in the
sham group (4.0 ± 0.7 mm/s venous pre vs 4.0 ± 0.5 mm/s venous post-sham, p value: 0.98) (Fig.
46b).
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Figure 46. Blood flow (mm/second) of the terminal mesenteric arteriole (a) and accompanying vein (b) pre‐
operatively, post‐sham, and post‐SBR at a location 6 cm from the ileal‐cecal junction. Asterisk indicates p <
0.05 as compared to pre‐op (pre‐op vs sham and pre‐op vs SBR). Number sign indicates p < 0.05 sham vs SBR.

5.1.3. Conclusions and discussion
SBR results in villus angiogenesis and intestinal adaptation [177]. While previous studies have
attempted to measure changes in blood flow following SBR using ex vivo methodologies and
surrogate markers of blood flow, this is the first study to examine the effects of intestinal
resection on hemodynamics using an in vivo imaging modality.
The present study demonstrates that PAM is a useful tool for measuring intestinal hemodynamics.
The use of hemoglobin as endogenous contrast eliminates the potential disturbance to the
intestinal

system

induced

by

exogenous

contrast.

High

spatial

resolution

enables

microenvironmental studies down to the level of the capillaries. The spatial resolutions of PAM
can also be scaled for deeper tissue imaging [8]. Real-time imaging ability provides for acute
response monitoring. In addition, the minimum invasiveness of PAM enables longitudinal
studies on the same animal.
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The results of the present study demonstrate that at baseline, prior to intervention, arterial and
venous sO2 of the terminal mesenteric artery and accompanying vein are similar. This may
indicate minimal to no tissue oxygen utilization of the supplied intestine. Previous ex vivo studies
of intestinal sO2 using radioactive microspheres have demonstrated a significant difference
between arterial and venous sO2 in both the fasting and the fed state of other animal models.
Stevenson and Weiss record in rats a 93.7% fasted arterial sO2 in comparison to a 35.8% fasted
venous sO2; fed arterial and venous sO2 were respectively similar.

Other studies have

demonstrated increased tissue oxygen uptake in piglets following oral feeds. In the present study,
animals were not fasted prior to measurement, but given free access to standard rodent chow,
making the timing of the animal’s last meal a variable factor. However, given the minimal
variability in the pre-operative measurements of both blood flow and oxygen saturation, this
appears to have had minimal effect. While this contradicts previous ex vivo studies in other
animal models, our in vivo results suggest either a high physiologic reserve in mice, and/or leftto-right shunting within the intestinal wall even with a metabolically active state.
Immediately following SBR, hemodynamic changes occur consistent with a reduced oxygen
delivery. Venous sO2 drops dramatically post-SBR. A less dramatic decrease in venous sO2 also
occurs post-sham, likely related to the metabolic effects of transection alone. It is unclear at this
point in time the significance of the drop in arterial sO2 post-SBR and post-sham. However, the
overall oxygen extraction fraction post-SBR increases significantly, representing increased tissue
oxygen utilization within the remnant bowel. Further, both arterial and venous blood flow
decreased post-SBR. Such decrease in blood flow was not seen post-sham and likely represents
an immediate reaction to ligation of 50% of the small bowel mesentery and vasculature, and not
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a reaction to the acute blood loss from the transected marginal artery of the intestine that occurs
both post-SBR and post-sham from the associated enterotomy.
Hypoxia is a well-recognized trigger of angiogenesis, resulting in the activation of hypoxiainducible factors (HIF), responsible for transcriptional activation of genes [182]. In states of
intestinal mucosal inflammation, HIFs have been shown to have a protective role. In a study by
Karhausen et al, transgenic intestinal epithelial overexpression of HIF-1 protected against
trinitrobenzene sulfuric acid-induced colitis, while loss of epithelial HIF-1 resulted in increased
colitis severity, weight loss, intestinal permeability, and mortality [183]. It is plausible that
cellular changes in response to hypoxia post-SBR may act in a similar manner, having a proangiogenic and protective role in the intestinal epithelium.
Previous studies of hemodynamic alterations following SBR have demonstrated a hyperemic
response to SBR [179-181], however the earliest time point studied in those experiments was 24
hours after resection. In contrast, the data from this study represents changes of the intestinal
microvasculature within the first hour post-SBR. It is unclear at this point in time the duration of
the hypoxic changes that occur immediately after resection, but further investigation is underway
to determine the changes in hemodynamics that occur as the bowel undergoes adaptation. Our
laboratory’s previous work has demonstrated an increased villus capillary blood vessel density
within the remnant bowel on post-operative day 7 [177]. Such new blood vessel growth may be
supported by increased blood flow as adaptation occurs.
Intestinal adaptation in response to massive SBR is a multifactorial process involving
angiogenesis, cellular proliferation, and apoptosis. Through the use of photoacoustic microscopy,
the immediate intestinal hemodynamic changes that occur after SBR, and resultant hypoxia, are
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novel findings that provide possible mechanistic insight into the changes that occur within the
remnant bowel within minutes of resection. The duration of intestinal hypoxia, cellular effects of
such hypoxic changes, and impact on villus angiogenesis remain to be studied. A better
understanding of hypoxia following SBR and the role of angiogenesis in intestinal adaptation
may help in the development of future therapeutic treatments for patients with short gut
syndrome.

5.2. Non‐invasive photoacoustic tomography and microscopy of mouse brain
metabolism in vivo
In mammals, the brain coherently controls the overall action of the body [184]. Performing
numerous computation-intensive tasks such as information processing, perception, motor control
and learning, brain tissue consumes a large amount of energy in proportion to its volume [185].
For example, humans devote 20-25% of their metabolism to the brain, where the energy is
mostly used for sustaining the electric charge (membrane potential) of neurons [185, 186]. In
humans and many other species, the brain gets most of its energy from oxygen-dependent
metabolism of glucose [185]. An abnormal metabolic rate of glucose and/or oxygen usually
reflects a diseased status of brain, such as cancer or Alzheimer’s disease [187, 188]. In addition,
physiologically active regions of the cerebral cortex consume more energy than inactive regions
[189]. These phenomena have formed the basis for functional brain imaging methods, including
positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) [190,
191].
However, PET depends on the administration of radioactively-labeled tracers (e.g., 2-deoxy-2fluoro-D-glucose, FDG), a complex procedure with exposure to ionizing radiation. fMRI is
primarily sensitive to deoxy-hemoglobin and suffers from slow imaging speed. Moreover, both
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PET and fMRI are expensive techniques with poor spatial resolutions. Therefore, a fast,
noninvasive and non-ionizing imaging modality with good spatial resolutions is needed to
advance metabolism-associated studies of brain physiology and pathology.
On the basis of the photoacoustic effect, photoacoustic tomography (PAT) solves the resolution
drawback of pure optical imaging and the contrast drawback of pure ultrasonic imaging [5-7,
192]. In PAT, photon energy absorbed by molecules is partially or completely converted into
heat, which thermoelastically induces pressure waves. The induced pressure waves are detected
by ultrasonic detectors to form an image [192]. PAT is capable of anatomical, functional,
molecular and metabolic imaging of small animals, with highly scalable spatial resolution and
penetration depth [6, 7, 193, 194]. Photoacoustic computed tomography (PACT) is a major
implementation of PAT, which aims at fast data acquisition, sub-millimeter resolution and deep
penetration depth beyond the optical diffusion limit [26, 195-197]. Noninvasive, label-free and
functional PACT of the rat brain was demonstrated by accurately mapping brain lesions and
cerebral hemodynamics [26]. Molecular imaging of a mouse brain tumor in vivo was also
performed with PACT, using IRDye-800-c as the contrast agent [195].
Here, for the first time, we have demonstrated that PACT is able to image glucose uptake in the
mouse brain, using a newly developed glucose analog 2-deoxy-2-[N-(7-nitrobenz-2-oxa-1,3diazol-4-yl)amino]-D-glucopyranose (2-NBDG). To demonstrate the metabolic imaging
capability of PACT, we studied in vivo forepaw stimulation responses. Our phantom and animal
studies showed that PACT could spectrally separate 2-NBDG and blood using two-wavelength
measurements, thus decouple the glucose and hemodynamic responses to the stimulations. Openscalp photoacoustic microscopy and fluorescence imaging were used to validate the results from
PACT.
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5.2.1. Materials and methods
2‐NBDG
2-NBDG is a newly developed fluorescent 2-deoxyglucose (2-DG) analog [192, 198-205]. Like
the FDG (molecular weight: 181) used in PET studies, 2-NBDG is transported into cells via the
same GLUT as glucose [204]. Once taken up by cells, 2-NBDG is phosphatized to 2-NBDG-6-P,
which prevents it from being released again from the cells. However, because of the lack of the
2-hydroxyl group needed for glycolysis, 2-NBDG-6-P cannot be further metabolized. Therefore,
the distribution of trapped 2-NBDG is a good reflection of glucose metabolism [203]. Because 2NBDG is a relatively small molecule (molecular weight: 342) (Fig. 1a), it crosses the bloodbrain-barrier much more easily than other near-infrared fluorophore-labeled 2-DG analogs, such
as IRDye800-DG (molecular weight: 1330) [192, 199]. Moreover, 2-NBDG has its peak
absorption at 478 nm, where hemoglobin has a much lower absorption [Figure 1b]. By carefully
controlling the laser fluence, the signal contribution from hemoglobin can be neglected at this
wavelength. These features have made 2-NBDG particularly suitable for brain studies.
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Figure 47. 2‐NBDG (C12H14N4O8). (a) Chemical structure. (b) Molar extinction spectra of 2‐NBDG, deoxy‐
and oxy‐hemoglobin.
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Noninvasive photoacoustic computed tomography (PACT)
Fig. 48a is the schematic of the PACT setup. An OPO laser (BasiScan 120, Spectra-Physics) is
pumped by a Nd:YAG laser (Brilliant B, Quantel) with a third harmonic generator (355 nm) to
provide pulses with wavelengths tunable from 420 nm to 680 nm. The pulse duration is 6 ns, and
the pulse repetition rate is 10 Hz. The laser beam is homogenized by an optical diffuser (EDC-5,
RPC Photonics) to provide uniform illumination over the mouse brain. The maximum light
intensity at the tissue surface is approximately 10 mJ/cm2, below the ANSI limit at the chosen
wavelengths. The photoacoustic signals are detected by a 5 cm diameter full-ring ultrasonic
transducer array with 512 elements (Imasonic, Inc.). The central frequency of the ultrasonic
transducer array is 5 MHz, and the 6-dB bandwidth is more than 80%. Each element in the array
is directly shaped into an arc to produce an axial focal depth of 19 mm. The combined foci of all
elements form a relatively uniform imaging region of 20 mm diameter and 1 mm thickness.
Within this region, the axial (radial) resolution is 0.10 mm, and the transverse (tangential)
resolution is 0.25 mm [206]. As show in Fig. 48b, after a complete data acquisition from all 512
elements, the raw data is reconstructed to form a photoacoustic image of the brain based on the
universal back-projection algorithm [207]. The imaging speed of the current system is 1.6 sec per
frame.

Optical‐resolution photoacoustic microscopy (OR‐PAM)
OR-PAM, another implementation of PAT, aims at capillary-level resolution within the optical
diffusion limit [7, 32, 36, 39, 80, 81, 208]. As shown in Fig. 48c, by focusing the laser pulses to a
diffraction-limit spot using an objective with an NA of 0.1 (AC127-050-A, Thorlabs), OR-PAM
achieves a transverse resolution of 5 µm. By using a single-element ultrasonic transducer with a
central frequency of 50 MHz and a 6-dB bandwidth of 100% (V214-BB-RM, Olympus-NDT),
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OR-PAM achieves an axial resolution of 15 µm. Due to scattering by the tissue, the penetration
depth of OR-PAM is limited to ~ 1 mm, which is sufficient for transcranial imaging of the
cerebral cortex but not transdermal imaging. The arrival time of the PA signal provides depth
information, and volumetric imaging is acquired by two-dimensional raster scanning of the
sample. In this study, to validate the cortical vascular image obtained by PACT, the same mouse
was imaged by OR-PAM at 570 nm after the PACT imaging. The scalp was surgically removed,
while the skull was left intact. It took about 30 min to acquire an OR-PAM image over a 5×10
mm2 area.

Fluorescence imaging
To confirm the stimulation induced changes in 2-NBDG uptake in brain, open-scalp fluorescence
imaging using the same experimental protocol was performed on a different mouse. The
fluorescence imaging system shown in Fig. 48d has been reported previously [205]. Briefly, the
light source is a 120-watt xenon arc lamp (Oriel Inc.) with an excitation filter (450 ± 20 nm,
FB450-40, Thorlabs). Fluorescence images are captured by a low-noise CCD camera (Meade
Inc.). An emission filter (550 ± 20 nm, FB550-40, Thorlabs) and an achromatic doublet (NT45265, Edmund) comprise the camera lens. In this study, the fluorescence images were acquired
with a CCD exposure time of 0.5 sec. White-light images were acquired with a CCD exposure
time of 0.05 sec after removing the emission filter and turning on the room light. Because blood
vessels appeared darker than the background in the white-light images, the image intensity was
reversed for better clarity.
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Figure 48. Photoacoustic and fluorescence imaging systems. (a) Schematic of the PACT system. (b) In PACT,
upon laser excitation, the time‐domain PA signals recorded by each transducer element are back‐projected
into the 2D imaging space based on the delay times, and then summed to form an image of the mouse cortex.
(c) Schematic of the OR‐PAM system, where the capillary‐level lateral resolution is provided by the tight
optical focusing. UT, ultrasonic transducer; CorL, correction lens; RAP, right‐angled prism; RhP, rhomboid
prism; SOL, silicone oil layer. (d) Schematic of the fluorescence imaging system.

Animal preparation
Female ND4 Swiss Webster mice (Harlan Laboratory, 16 to 20g) were used for the current study.
The laboratory animal protocols for this work were approved by the Animal Studies Committee
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of Washington University in St. Louis. To enhance 2-NBDG uptake, the mice were fast for 24 h
before the experiment [204]. Before imaging, the hair on each mouse’s head was removed with a
depilatory. An intraperitoneal dose of 90 mg/kg ketamine plus 10 mg/kg xylazine was used for
anesthesia. The mouse was then taped to a lab-made animal holder, which was then mounted to
the PACT system. Instead of being fully immersed in water, the animal was supported from
below, with the head being covered by a flexible membrane. The entire experiment took less
than one hour, therefore additional injection of the anesthetic mixture was not needed. The
animal preparation for OR-PAM and fluorescence imaging were similar, except that there was no
water coupling for fluorescence imaging. Three mice were used for PACT and subsequent ORPAM imaging, and one mouse was used for fluorescence imaging.

Forepaw stimulation
Thirty minutes after the injection of 0.3 mL 3 mM 2-NBDG via the tail vein, stimulations were
introduced by two pairs of needle electrodes inserted under the skin of the right and left forepaws,
respectively. The electrodes were connected to a function generator (DS345, Stanford Research
Systems) through a manual switch. The whole procedure consisted of four periods, each lasting
for 3 min (Fig. 49a). The first and third periods (P1 and P3) were resting states, while the second
period (P2) was right paw stimulation (RPS) and the fourth period (P4) was left paw stimulation
(LPS). Each stimulation period consisted of a train of electrical pulses with an amplitude of 2
mA, a pulse width of 0.25 sec and a repetition rate of 2 Hz (Fig. 49b). PACT acquired images
continuously through the four periods. The procedure was first performed for 12 minutes at 478
nm and then repeated for 12 minutes at 570 nm after a delay of 10 min. We assumed that brain
responses were repeatable within the time window of the experiment.
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Figure 49. Time course of forepaw stimulation. (a) At each wavelength, the procedure consisted of four
periods: two resting periods (P1 and P3) and two stimulation periods (P2 and P4). Each period lasted for 3
min. (b) Each stimulation period consisted of a train of electrical pulses with an amplitude of 2 mA, a pulse
width of 0.25 sec and a repetition rate of 2 Hz.

Image co‐registration
Before quantitative analysis, the PA images at 570 nm from OR-PAM and PACT were coregistered by using a MATLAB Image Processing Toolbox (R2010b, Mathworks, Boston, MA).
Here, a 2D rigid registration was performed, which included linear translation, scaling, and
rotation. The first step was to manually select 10-20 control points in the two images. The spatial
translation, scaling and rotation matrix was computed based on the coordinates of these control
points. The entire OR-PAM image was then transformed and registered to the PACT image
using this matrix. To show the co-registration performance, the co-registered OR-PAM image
was superimposed on top of the PACT image, with the overly transparency proportional to the
OR-PAM image pixel values.
Signal processing
In PACT, for both phantom and in vivo studies, the images acquired at 478 nm and 570 nm were
used to reconstruct the distribution of 2-NBDG and hemoglobin, respectively. Since deoxy- and
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oxy-hemoglobin have the same absorption coefficients at 570 nm, the PA signal amplitude was
proportional to the total hemoglobin concentration C Hb , an index for blood perfusion.
For open-scalp OR-PAM, because the mouse skull is translucent, the attenuation of light due to
the skull was neglected. The laser fluence measured at the skull surface is a good approximation
of the actual fluence at the blood vessels. Therefore, C Hb can be estimated as [209]

CHb 

570
VOR
.
570 570
kOR Hb
FOR

(12)

Here, the subscript OR denotes the OR-PAM system and the superscript 570 denotes the
wavelength. kOR is a calibration factor measured from blood in a clear medium, which
570
is the molar
incorporates the system detection efficiency and Grueneisen coefficient.  Hb
570
extinction coefficient of hemoglobin at 570 nm, FOR
is the laser fluence at the skull surface, and
570
VOR
is the OR-PAM signal amplitude.

Because PACT shares the same absorption contrast as OR-PAM, the calibrated C Hb from ORPAM can be directly transferred to PACT once the images from the two systems are coregistered. We estimate the calibration factor kCT for PACT by

kCT

VCT570
.

570 570
CHb Hb
FCT

(13)

570
is the laser fluence measured at the scalp
Here, the subscript CT denotes the PACT system. FCT
570
surface and VCT
is the PACT signal amplitude. In addition to the system detection efficiency
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and Grueneisen coefficient, kCT also incorporates an attenuation factor of the laser fluence at 570
nm, which cannot be neglected in PACT owing to the scalp.
The fluence attenuation of the scalp is wavelength dependent. However, the effective attenuation
coefficients of the nude mouse scalp at 478 nm (7.1 cm-1) and 570 nm (6.5 cm-1) are
approximately the same [210], and the mouse scalp is relatively thin (less than 1.5 mm) [211].
Therefore, the fluence attenuations at the two wavelengths were treated as the same. We also
assumed that the heterogeneity of the scalp was negligible. Accordingly, we can estimate the 2NBDG concentration C2 NBDG as

C 2  NBDG 

VCT478

 2  NBDG FCT478
k CT  2478
 NBDG

(14)

Here,  2478
 NBDG is the molar extinction coefficient of 2-NBDG at 478 nm. 2 NBDG is the
conversion efficiency from absorbed optical energy to heat, which is 45% for 2-NBDG [212].
The conversion efficiency for hemoglobin is absent in Eq. 13 because it is 100%.
Eqs. (12-14) can be used to estimate the absolute concentrations of hemoglobin and 2-NBDG in
the brain. Because the absolute baseline signals vary across the brain, relative changes are more
robust for quantifying the responses induced by stimulations. However, it is also important to
demonstrate the absolute imaging capability of PACT, which is useful for the baseline mapping.
In addition, the future quantification of the metabolic rates of oxygen and glucose requires the
absolute concentrations.
In forepaw stimulations, PACT images acquired during each period (P1-4) were averaged at each
wavelength to increase the signal-to-noise ratio. The relative changes were computed as (P2 – P1)
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/ P1 for RPS, and as (P4 – P3) / P3 for LPS. Only pixels with amplitude above 1.5 times the noise
level were used for calculation. In response quantifications, only pixels with response magnitude
above 10% of the maximum magnitude were averaged. The same procedure was also applied to
the fluorescence imaging results.
Response areas at the two wavelengths were also quantified. Here, the response area was defined
by the pixels with a response magnitude above 10% of the maximum response magnitude. The
cortical area covered by the responding vessels was estimated as well. An ellipse equation was
used to fit the outline of the responding vessels, with the center, major axis, minor axis and
orientation as the fitting variables. The area of the best fit ellipse was approximated as the
covered area.

5.2.2 Results
PACT of 2‐NBDG and blood phantom
A phantom study was first performed to validate the spectral separation of 2-NBDG and blood.
As shown in Fig. 50a, whole bovine blood (hemoglobin concentration: 2.5 mM) and 0.4 mM 2NBDG solution were embedded in gelatin and imaged by PACT at 478 nm and 570 nm. This 2NBDG concentration was close to the estimated 2-NBDG concentration in animal studies to be
performed later. The ratios between the averaged PA signal amplitudes of 2-NBDG and blood at
478 nm and 570 nm were 9:1 and 0.06:1, respectively (Fig. 50b). Blood was almost invisible at
478 nm, so was 2-NBDG at 570 nm. The PA amplitude of the 2-NBDG sample happened to be
nearly identical to (0.98 times) that of the blood sample at 570 nm. Therefore, 2-NBDG and
blood could be separated as shown in Fig. 50c. In addition, we found that 2-NBDG was more
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diffusive than hemoglobin (molecular weight: 64,458) in gelatin, due to the much smaller size of
2-NBDG molecules.

Figure 50. Multi‐wavelength PACT in vitro and in vivo. (a) Photograph (left) and PACT images (middle and
right) of whole bovine blood and 0.4 mM 2‐NBDG in a gelatin phantom. (b) Averaged PA amplitudes from
blood and 2‐NBDG, normalized by the PA amplitude of blood at 570 nm. (c) Spectral separation of blood
(shown in red) and 2‐NBDG (shown in blue). CHb: total hemoglobin concentration; C2‐NBDG: 2‐NBDG
concentration. (d) Photograph of a mouse brain with its scalp intact (top) and removed (bottom). SS: sagittal
sinus; CS coronal suture. (e‐f) PACT images of the mouse brain at (e) 2‐NBDG‐dominant 478 nm and (f)
hemoglobin‐dominant 570 nm, respectively. (g) Spectral separation of blood (shown in red) and 2‐NBDG
(shown in blue) in the brain.

PACT of mouse brain
Figs. 50e-f are noninvasive PACT images of a mouse brain, acquired 30 min after 2-NBDG
administration. At 478 nm, the PA signal amplitudes reflected the 2-NBDG concentration in the
brain tissue (Fig. 50e). At 570 nm, the PA signal amplitudes reflected the total hemoglobin
concentration in blood vessels (Fig. 50f). Cortical vascular landmarks including the sagittal sinus
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(SS) and coronal suture (CS) were clearly imaged by PACT and confirmed by open-scalp
photography. A merged image of CHb and C2-NBDG is shown in Fig. 50g, where 2-NBDG signals
from blood vessels were excluded. The hemoglobin distribution was superimposed on top of the
2-NBDG distribution, with the transparency of the hemoglobin layer proportional to its pixel
values. Capillary-level OR-PAM images of the same mouse are shown in Figs. 51a-b. The coregistration results show that the transdermal and transcranial PACT image agreed well with the
open-scalp OR-PAM image, as shown in Fig. 51c-d.

Figure 51. High‐resolution OR‐PAM imaging of the mouse brain after PACT imaging. (a) OR‐PAM image of the
mouse brain, acquired at 570 nm with the scalp removed and the skull left intact. CHb: total hemoglobin
concentration; SS: sagittal sinus; CS: coronal suture. The numbers denote representative control points
selected for image co‐registration. (b) Close‐up of region inside the dashed box in (a) showing the dense
capillaries in the brain cortex. CP: capillary. (c) PACT image of the same mouse brain with intact scalp and
skull. The numbers denote the control points corresponding to those in (a). (d) Co‐registered OR‐PAM image
(shown in color) superimposed on the PACT image (shown in gray).

PACT of cortical responses to forepaw stimulations
Fig. 52a-b are the relative changes of PA signals induced by forepaw stimulations. At 478 nm
(Fig. 52a), the RPS and LPS caused PA signal amplitudes to increase by 3.6% ± 2.2% and 2.0%
± 1.1% in the somatosensory region (SR) of the contralateral hemisphere, respectively. Such
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increases indicate elevated glucose uptake rates, and thus reflect increased neuron activity. Under
the two stimulations, the response areas were 5.7 ± 1.3 mm2 and 7.4 ± 2.5 mm2, respectively.

Figure 52. PACT of the cortical responses to forepaw stimulations. (a‐b) Relative changes of the PA
amplitudes (shown in color) acquired at (a) 2‐NBDG‐dominant 478 nm and (b) hemoglobin‐dominant 570
nm under the right paw stimulation (RPS) and left paw stimulation (LPS), superimposed on the resting‐state
image (shown in gray). The threshold for the overlay transparency was set to be 10% of the maximum
response. (c) Overlaid images showing the relative changes of 2‐NBDG concentration (C2‐NBDG, shown in
blue) and total hemoglobin concentration (CHb, shown in red), superimposed on the resting‐state image at
570 nm (shown in gray). (d) Relative changes of C2‐NBDG and CHb averaged over three mice. Error bars:
standard deviation. The p values were calculated from paired Student’s t‐test between stimulated states P2 or
P4 and resting states P1 or P3.

Similarly, at 570 nm (Fig. 52b], the RPS and LPS caused PA signal amplitudes to increase by 6.4%
± 5.3% and 3.2% ± 2.9% in the contralateral hemisphere, respectively. Such changes indicate an
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increase in total hemoglobin concentration arising from elevated inflows of fresh blood, and thus
reflect increased neuron activity as well. Under the two stimulations, the response areas were 4.7
± 1.5 mm2 and 4.5 ± 1.2 mm2, respectively. Furthermore, the responding vessels covered much
larger cortical regions of 16.5 ± 3.3 mm2 and 15.1 ± 2.5 mm2, respectively, as shown in Fig. 53a.
The areas covered by the responding vessels were significantly wider than the 2-NBDG response
areas for both RPS and LPS, with p values less than 0.05 (Fig. 53b).

Figure 53. Quantification of the cortical region covered by responding vessels. (a) An ellipse was used to fit
the outline of the responding vessels, with the center, major axis, minor axis and orientation as the fitting
variables. (b) Quantification of hemoglobin response area, 2‐NBDG response area and cortical region covered
by responding vessels, averaged over three mice. Error bars: standard deviation. The p values were calculated
from paired Student’s t‐test between the 2‐NBDG response area and the cortical region covered by
responding vessels.
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In addition, the linear regression shows that the 2-NBDG response amplitude was approximately
proportional to that of the hemoglobin response for both RPS and LPS, with ratios of ~0.48 and
~0.52, respectively (Fig. 54a). Similarly, the ratios between the 2-NBDG response area and the
area covered by the responding vessels were ~0.41 and ~0.57 for RPS and LPS, respectively (Fig.
54b). The high correlation of the two responses may reflect the close coupling between oxygen
metabolism and glucose metabolism in the brain.
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Figure 54. Correlation of the hemodynamic response and glucose response. (a) Linear regression of the 2‐
NBDG response amplitude and the hemoglobin response amplitude for RPS and LPS on three mice. (b) Linear
regression of the 2‐NBDG response area and cortical area covered by responding vessels for RPS and LPS on
three mice.

Fluorescence imaging of cortical responses to forepaw stimulations
First, whole bovine blood and 2-NBDG (0.4 mM) were enclosed in 1 mm diameter glass tubes
and imaged by our fluorescence setup (Fig. 55a). The fluorescence image shows that blood did
not generate fluorescence while 2-NBDG did profusely.
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Second, using the same experimental protocol as in PACT, we imaged the cortical responses to
forepaw stimulations on a different mouse using the fluorescence setup. The results are shown in
Fig. 55b. While the white light image shows the detailed cortical vasculature, the fluorescence
image shows the 2-NBDG distribution and thus the glucose metabolism. The RPS and LPS
induced fluorescence intensity to increase by 5.1% and 6.2% in the SR of the contralateral
hemisphere, respectively. Such increases indicate elevated glucose uptakes in the SR, which
qualitatively agree with the glucose responses assessed by PACT.

Figure 55. Fluorescence imaging of mouse brain responses to forepaw stimulations. (a) Left: intensity‐
reversed white‐light image of two glass tubes filled with 2‐NBDG (0.4 mM) and whole bovine blood. Right:
fluorescence image of the two tubes. (b) Relative changes of the fluorescence intensity under RPS and LPS
(shown in color), superimposed on the intensity‐reversed white‐light image of the brain cortex (shown in
gray), with the scalp removed and skull left intact. The threshold for the overlay transparency was set to be
10% of the maximum response.

5.2.3. Conclusions and discussion
The pathways of oxygen metabolism and glucose metabolism are closely coupled in neuron
activity. One of the recent uses of PACT is the label-free measurement of metabolic rate of
oxygen (MRO2) [5, 39]. Currently, except for blood flow speed, PACT can measure all the other
parameters required for quantifying MRO2, namely vessel cross-section, oxygen saturation and
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total concentration of hemoglobin, and tissue volume. Recently, a few PA methods have been
proposed for blood flow measurement in deep tissue, which may be applicable to PACT [76-78,
213]. Therefore, PACT has the potential to simultaneously image the two metabolic pathways:
oxygen metabolism as described by others, and glucose metabolism as shown in this paper.
Previous studies by PET and fMRI have shown that forepaw stimulations can increase the
cerebral metabolic rate of oxygen (CMRO2) [214-216]. Because the blood oxygenation change is
much smaller than the blood flow change, such increase in CMRO2 is mainly attributed to the
elevated blood perfusion [214-216]. In our results, the intensified photoacoustic signal at 570 nm
provided a direct evidence of the increase in blood perfusion. For absolute CMRO2 quantification,
our future work will incorporate the oxygenation measurement by using multiwavelength
measurements.
In addition, we found that the glucose response area was confined within the SR, while the
hemodynamic response area was much larger than that. Glucose response was a focal activity
restricted to neurons responsible for the stimulated site. In contrast, hemodynamic response was
less spatially restricted since fresh blood must be delivered from the major feeding arteries,
through the capillaries of the SR, to the major draining veins. Moreover, the hemodynamic
response may spread into neighboring vessels of the same vascular network.
Except for the dimensional discrepancy, the glucose response area was more homogenous than
the hemodynamic response area. The latter was characterized by a strong vascular pattern.
Moreover, there was a clear core for the glucose response, which is indicated by the double
arrows in Fig. 52a. Such a core was not seen in the hemodynamic response. This again suggests
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that glucose response was a focal activity. The core region contained the neurons most sensitive
to the stimulated site.
In summary, using 2-NBDG as the exogenous contrast and hemoglobin as the endogenous
contrast, we have demonstrated that PACT is capable of imaging the metabolic response of a
mouse brain to forepaw stimulations. As a quantitative imaging modality, PACT can spectrally
separate 2-NBDG and hemoglobin by virtue of its optical absorption contrast. As a fast imaging
modality, PACT can acquire a volumetric image in less than two seconds with a laser repetition
rate of 10 Hz. This imaging speed can be further improved by a laser system with higher
repetition rate and automatic wavelength switch. As a deep imaging modality, PACT can
transdermally and transcranially localize the spatial patterns of the brain responses by virtue of
its high ultrasonic resolution. With all these merits, we expect PACT to be applied to more brain
metabolism studies in the future.

6. Future work
PAM has the following notable features: (1) PAM has highly scalable spatial resolution and
maximum imaging depth in both the optical and acoustic domains. (2) PAM images optical
absorption contrast with 100% sensitivity, and provides images without speckle artifacts. (3)
PAM can essentially image all molecules at their absorbing wavelengths. (4) PAM is capable of
functional and metabolic imaging in absolute units using endogenous contrast agents.
As in modern optical microscopy, it is possible to combine multiple optical objectives with
different magnification powers to a single OR-PAM system for fast resolution switching.
However, the confocal alignment of the optical illumination and acoustic detection needs to be
maintained. Typically, a microscope objective with a higher NA comes with a shorter focal
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length. To keep the imaged object in focus, one solution is to use a specially designed parfocal
lens, which is capable of varying the effective NA without changing the optical focal length.
Similarly, it is also possible to integrate multiple ultrasonic transducers with different central
frequencies into a single AR-PAM system, while keeping the same illumination. Furthermore,
OR-PAM can be combined with AR-PAM as a single device to cover a wider scale range. Since
OR-PAM and AR-PAM can share the same detection, only the optical illumination needs to be
integrated.
Integration between PAM and other imaging modalities can provide complementary contrasts,
thus is a direction for future PAM development. So far, PAM has been integrated with backscattered optical microscopy (scattering contrast) [217], fluorescence microscopy (fluorescence
contrast) [132, 158, 218], optical coherence tomography (scattering contrast) [132, 219], twophoton microscopy (fluorescence contrast) [220] and pulse-echo ultrasound imaging (mechanical
and elastic contrast) [221, 222]. In these integrated systems, the two sub-systems share either the
same illumination or detection. Therefore, their images are inherently co-registered. In addition
to providing complementary contrast, PAM has been combined with a high intensity focused
ultrasound (HIFU) system for therapeutics, where PAM is used to outline the location and shape
of tumors and guide the subsequent HIFU therapy or drug release [145, 223]. In addition to the
integration of instrumentations, new exogenous contrast agents have also been integrated for
multi-modal systems. For example, perfluorocarbon nanoparticles loaded with near-infrared dyes
have been used as a dual contrast agent for fluorescence imaging and PAM imaging [224].
Another direction is to miniaturize the PAM system for internal organ and intravascular imaging
[168, 225-231]. The first sideway looking photoacoustic endoscope (PAE) with a 4.2-mmdiameter probe has been demonstrated in acoustic-resolution mode for functional esophagus and
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colon imaging on small animal models [225, 227]. The bottleneck for further miniaturization of
the PAE probe involves integrating the light delivery fiber with a conventional piezoelectric
transducer. Despite the complex fabrication procedures for miniature piezoelectric detector, its
detection sensitivity decreases with its size. By contrast, optical detection of ultrasound pressure
using a transparent Fabry-Perot sensor may be an alternative solution [232]. Theoretically, PAE
should enjoy the same scalability as PAM. Since most cancers start from the epithelial layer,
PAE can be implemented in optical-resolution mode for high-resolution epithelial imaging of
early-stage cancer [225-227]. Delivery of coupling medium for acoustic propagation remains
another challenge for PAE imaging of internal lumens such as the trachea and gastrointestinal
(GI) tract. It has been suggested that water and ultrasound gel can be introduced to the GI tract
[226, 227]. However, it is challenging to apply water to the respiratory system. An inflatable
balloon with a water filling channel could be a solution [233]. By contrast, it is less problematic
for intravascular PAE imaging since blood is a natural acoustic coupling medium. However, the
strong absorption of blood in the visible spectral range requires the use of near-infrared
wavelengths. Alternatively, blood can be flushed with saline.
As a maturing imaging technique, PAM is expected to find new applications in both fundamental
life science and clinical practice, which include but are not limited to tumor angiogenesis,
lymphatic dynamics, neural activity, brain metabolism, cancer detection, drug delivery and
intraoperative monitoring. While PAM has been commercialized for pre-clinical applications,
future commercialization for clinical applications will greatly accelerate the translation of PAM
from a lab technology to a mainstream imaging modality.
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